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Abstract and Keywords 
Objective:  
To evaluate the relationship between perceived social support and HRQOL (physical and 
emotional) in low SES breast cancer survivors.    
Methods:  
A cross-sectional study design was used to measure perceived social support at 18 
months and HRQOL at 3 years after breast cancer diagnosis using MOS SS and MOS 
SF-36, respectively. Multiple regression analyses were used to evaluate the relationship. 
Results: 
Menopause at the time of diagnosis, adjunct chemotherapy, adjunct radiation therapy, co-
morbidities, treatment side effects and depression were negatively associated with PCS 
scores (p < 0.01). Treatment side effects, anxiety and depression were negatively 
associated with MCS scores (p < 0.01).   
Conclusions: 
Perceived social support was not associated with HRQOL in low SES breast cancer 
survivors in our study. Menopause, co- morbidities, treatment side effect, adjunct 
chemotherapy and radiation therapy adversely affect physical HRQOL. Feelings of 
anxiety, depression and treatment side effects have a negative impact on emotional 
HRQOL.  
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   Chapter 1 
Introduction and Research Objectives 
Breast Cancer    
Breast cancer is a chronic disease which stems from abnormal proliferation of cells in the 
breast tissue. Breast tissue extends from the collarbone and armpit across the ribs on both 
sides of the breastbone or sternum. The sternum lies in the middle of the front of chest. 
Breast tissue consists of skin, nipple, fat tissue, milk producing glands called lobules and 
ducts that carry milk from glands to the nipple.   
Abnormal proliferation of cells in the breast tissue results in formation of a mass or growth 
known as a tumour.  The abnormally proliferating cells in a tumour are known as tumour 
cells or malignant cells.  Malignant cells can spread to the surrounding chains of lymph 
nodes and to other areas of the body.  Breast cancer is diagnosed when a malignant tumour is 
present in the breast tissue with or without lymph node involvement or spread to distant areas 
of the body.  There are two main types of breast cancers; the most common type starts in the 
ducts and the second type starts in the lobules within the breast tissue (1).  
Breast cancer predominantly affects women; it is a rare disease among men.  Factors 
predisposing women to breast cancer include: increasing age, genetic predisposition, family 
history of breast or ovarian cancer, early menarche (women getting periods before age 12 
years), late menopause (after 55 years of age) and first pregnancy after 30 years of age or 
never being pregnant.  Known risk factors for breast cancer include consuming more than 2 
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glasses of alcoholic drinks per day, hormone replacement therapy with estrogens, obesity and 
radiation to chest area for treatment of other cancers (1). 
Burden of Breast Cancer  
Every year ten million patients are diagnosed with cancer worldwide and women make up 
almost half of this patient population (2). One fifth of the 4.7 million women diagnosed with 
cancer each year suffer from breast cancer (3).   Therefore, breast cancer is one of the most 
commonly diagnosed cancers among women worldwide (4).  Incidence rates for breast 
cancer are subject to regional variations and some developed nations such as US and Canada 
have higher incidence rates than other developed or developing countries (3).   
North America has one of the highest incidence rates for breast cancer in the world (3).  It is 
estimated that in 2011, 230,000 new cases of breast cancer were diagnosed in US (5) and 
23,000 new cases of breast cancer were diagnosed in Canada (6).  Breast cancer is the most 
common cancer affecting Canadian women (6).  Approximately 27% of Canadian women 
newly diagnosed with cancer have breast cancer (7) and 11.3% of Canadian women have a 
lifetime probability of developing breast cancer (6).  Breast cancer is also the most common 
cancer among women in Ontario where more than 9,000 women were diagnosed with the 
disease in 2011 (6).  
Women diagnosed with breast cancer are surviving longer due to early detection and better 
treatment options (8).  The 5-year survival rates for breast cancer patients have improved 
over the last four decades from almost 60% to 90% in the US (9) and 88% in Canada (6).  As 
a result of increased incidence and survival rates, more women are living with breast cancer 
today.  In Canada, the number of breast cancer survivors exceeded more than 152,000 in 
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2007 (6).  Current statistics indicate that after diagnosis with breast cancer, 82% of women 
survive for more than 10 years and 75% of women survive for more than 15 years in the US 
(9).   
Chronic illnesses such as cancers result in direct as well as indirect medical costs to the 
health care system.  Direct medical costs account for hospital stays, doctors’ appointments 
and drug costs.  Indirect medical costs include costs of private expenditures for home care, 
premature death and loss of productivity.  In 1998, the total economic burden of illness in 
Canada was reported to be $174.7 billion or 9% of the country’s gross domestic product.  Out 
of this, $93 billion was attributed to chronic disease (10, 11). The economic burden of cancer 
care in Canada is estimated to be $17.1 billion per year in direct and indirect medical costs. 
The direct health care or medical costs of all cancers in Canada each year are $4.2 billion.  
Productivity losses due to premature death and disability as a result of all cancers, cost the 
Canadian economy $12.9 billion every year (12).   
In 1995, the total lifetime cost of treatment for all women with breast cancer in Canada was 
over $454 million; average expenditure per breast cancer patient was estimated to be more 
than $25,000 per year (12). The average costs of breast cancer care to health care systems are 
similar in all provinces and territories in Canada; however, additional costs for cancer care 
have been reported in the province of Ontario.  Women with breast cancer in the province of 
Ontario are subjected to higher monthly out of pocket costs for patients such as costs of home 
health care, vitamins, alternative medicines and family care that are not covered by the 
provincial health plan (13). 
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Breast Cancer Care 
Organizations such as Public Health Agency of Canada, American Society of Clinical 
Oncology (ASCO) and World Health Organization (WHO) have established detailed clinical 
practice guidelines for preventive strategies and treatment modalities for breast cancer care. 
To decrease the incidence and reduce global burden of breast cancer, the WHO provides a 
model for breast cancer care focusing on earlier detection and treatment. Early detection or 
screening strategies include surveillance with regular clinical breast examinations and 
mammography for women as well as identification of women with high risk of developing 
breast cancer and providing them with counselling and options for preventive care (14).  In 
Canada breast cancer screening through biannual mammograms is recommended for women 
over 50 years of age (15, 16).  Treatment of breast cancer may involve surgery, radiation 
therapy, chemotherapy, hormonal therapy, or a combination of these therapies depending on 
the stage of disease. The ASCO guidelines provide an update on treatment modalities 
available according to the stage of breast cancer (17).   
In addition to preventive strategies and incorporating latest treatment modalities, clinical 
practice guidelines for breast cancer care in Canada focus on follow-up strategies and topics 
relevant to follow-up after treatment for breast cancer (18).  According to the Canadian breast 
cancer care guidelines, it is during the follow-up period that physical and psychological 
issues can be identified and interventions initiated (18).  Psycho-social problems are most 
prominent during the first year after breast cancer diagnosis and reduce considerably after 6 
years in the absence of recurrence or worsening of existing illness (19).   
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One aspect of breast cancer care that is not adequately discussed in the Canadian breast 
cancer care guidelines is the role of social support in breast cancer care (19).  Social support 
is known to improve relationships and general well-being among healthy individuals as well 
as those suffering from other chronic diseases (18).  There is limited research on social 
support and its effect on quality of life in women with breast cancer; however, future 
research on the subject has the potential to improve considerably, the existing clinical 
practice guidelines (19). 
Breast Cancer Research  
The focus of breast cancer clinical trials and observational studies in the last four decades has 
mainly been on histopathology, classifying stage of breast cancer, physical symptoms, 
treatment modalities and psychological distress of breast cancer patients (20).  These clinical 
trials and observational studies have improved screening and provided better treatment 
options for women with breast cancer. Improved screening methods and treatment modalities 
have led to improved survival in breast cancer patients (21). 
Numbers of women living with breast cancer are increasing due to an increase in incidence as 
well as longer survival rates.  This increase has forced researchers to adopt a multifaceted 
approach to breast cancer research, incorporating measures designed to improve quality of 
life for survivors of breast cancer (22). Cancer clinical trials consider health related quality of 
life (HRQOL) as an important end point in determining the efficacy of treatment modalities 
in breast cancer patients (23).  Canadian clinical practice guidelines emphasize the need for 
further research on HRQOL in breast cancer patients to improve health care delivery and 
reduce the long term health care costs among Canadian breast cancer survivors (18).   
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Quality of life is a multidimensional concept which incorporates subjective evaluations of 
both positive and negative aspects of life (24). Several domains are measured to assess 
quality of life; these domains include housing, neighbourhood, job, schools and health. 
HRQOL encompasses those aspects of quality of life which affect physical or mental health 
(25).  In addition to the advantages to individual breast cancer patients, assessment of 
HRQOL is beneficial in organizing public health prevention programs and introducing policy 
recommendations (24).  
Individuals benefit from knowledge regarding their physical and mental well-being and 
impact of factors associated with their well-being during the course of their illness. Through 
identification of subgroups with poor perceived HRQOL, it is possible to determine factors 
which may be linked to the poor perception of HRQOL and thus help policy makers to 
allocate resources based on unmet needs of the identified subgroups. In addition, data from 
HRQOL surveys can be useful in strategic planning and monitoring of effects of intervention 
at the community level (24).    
Measuring HRQOL is a challenge because experiences of individuals are different and may 
vary over time.  Determinants of HRQOL include socio-demographic factors such as age, 
socio-economic status, education, marital and family demands, disease-related factors such as 
stage of disease, treatment modalities and side effects of medicine, access to medical care 
and social supports available (26). 
The Merriam Webster dictionary defines “social” as ‘of or relating to human society, the 
interaction of the individual and the group, or the welfare of human beings as members of 
society’ and “support” as ‘to assist, help or advocate for’ (27, 28). Social support is a 
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multifaceted concept with more than 25 definitions of social support being used across 
various disciplines and research areas (29). Williams et al. studied the unique and shared 
properties of these working definitions and defined social support as ‘an amalgam of 
structure, type and strength of social relationships.’ In addition, social support also entails the 
degree of reciprocity, accessibility and reliability within the social relationships (29). 
Williams et al. emphasized that social support is best defined in the context of its use; in the 
context of HRQOL among patients suffering from chronic illness, social support is defined as 
“availability of support which refers to the degree to which interpersonal relationships serve 
a particular function” (30).   
Social support is an important predictor for coping with difficult circumstances and adjusting 
to the psychological as well as social demands placed on women who have been diagnosed 
with breast cancer (31).  Several studies indicate that perception of close supportive 
relationships with their spouse and family members is positively correlated with coping and 
adjustment by women diagnosed with breast cancer (26, 32, 33).  Availability of social 
support such as the presence of supportive family, friends and social networks is positively 
associated with HRQOL (26).  
Instead of counting the number of individuals available to provide support, perceived social 
support takes into account personal impressions of the degree of usefulness of social support 
rather than just presence of support (31).  Thus, evaluation of perceived social support is 
more subjective than objective in nature.  
Social support is a determinant of increased survival among women diagnosed with breast 
cancer (34); however, due to the subjective nature of assessment of perceived social support 
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there is limited literature on its impact on HRQOL in breast cancer survivors. Most studies 
analysing the effects of social support on HRQOL have used structural support i.e. number of 
individuals available to provide support rather than using perceived social support as a 
measure for social support (23, 26).  
 Despite its importance, no study to date has explored the relationship between ‘perceived 
social support’ and HRQOL in women with breast cancer with low socio economic status 
(SES).  Therefore, future direction for research in breast cancer entails further exploration of 
the relationship between perceived social support and HRQOL among women with lower 
SES.   
Research Objectives 
Women diagnosed with breast cancer suffer from a physically and emotionally debilitating 
illness.  These women often undergo protracted treatments and are subject to associated 
economic burdens in addition to the physical and psychological toll of the disease itself.  Due 
to the economic burden of breast cancer treatment and rehabilitation, women belonging to 
lower economic strata face additional challenges when diagnosed with breast cancer.  
HRQOL is an important outcome to evaluate in order to ensure optimal quality of care for 
women with breast cancer; especially among women identified as being particularly 
vulnerable such as those belonging to lower SES.  
Through our exploratory research we aim to contribute to the understanding of the 
relationship between perceived social support and HRQOL among low income women. Our 
objectives are to: 
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1. Determine the association between perceived availability of social support and physical 
HRQOL in low SES women diagnosed with breast cancer. 
2. Determine the association between perceived availability of social support and emotional 
HRQOL in the same population of women. 
Importance of our study  
Our research will better inform the clinical practice guidelines for breast cancer care.  At 
present the guidelines suggest psychosocial counselling for women diagnosed with breast 
cancer without specific goals for such counselling (18).  While we believe that the 
biomedical model of breast cancer care is vital, it does not take into account all of the 
complex factors involved in breast cancer care. We posit that a broader, more integrative 
framework, which includes psycho-social factors such as social support, is necessary. 
Through our study, the guidelines can be improved to incorporate specific goals of 
psychosocial counselling. 
Evidence suggests that improvements in HRQOL as a result of social support such as more 
visitors and support for women in labor result in decreased morbidity and as a result reduce 
medical costs (35). More than just diagnosis, breast cancer is costly to the Canadian health 
care system (10-13).  Improvements in HRQOL can decrease both the direct and indirect 
costs by improving general health of patients diagnosed with breast cancer.   
The survey for the study was conducted in California, USA.  Despite many differences, the 
Canadian and U.S health care systems have some similarities. Universal health care in 
Canada covers all the costs of diagnosis and treatment for Canadian residents; although there 
is no universal  health coverage, U.S states like California have government funded programs 
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which cover the cost of breast cancer treatment for low-income women diagnosed with breast 
or cervical cancer (36-38).  Populations in California and Canada are comparable in terms of 
size (close to 37 and a little over 34 million respectively) and demographic characteristics 
such as large immigrant populations with several ethnic minorities.  The burdens of breast 
cancer such as availability of treatment options for breast cancer and cost to the health care 
system for treating breast cancer patients are also similar in California and Canada.  
Immigrant populations in both countries face similar challenges in terms of accessing health 
care (41, 42).  Given the similarities, the results generated from this study can have relevance 
to the Canadian population as well.   
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Chapter 2 
Literature Review 
 
Literature Review Strategy 
The key words based on our research question were identified as the first step of literature 
review.  Breast cancer, social support and quality of life were the three key words identified.  
The primary source of literature for our study was Pub Med; PsycINFO and EMBASE were 
used as secondary sources of literature. 
The three key words in our study had the following MeSH (Medical Subject Heading) terms 
available: 
1. Breast Cancer 
a. MeSH: “Breast Neoplasm” 
2. Quality of Life 
a. MeSH:  “Life Qualities” 
b. MeSH:  “Life Quality” 
3. Social Support 
a. MeSH:  “Support, Social” 
b. MeSH:  “Social Networks” 
c. MeSH:  “Network, Social” 
d. MeSH:  “Networks, Social” 
e. MeSH:  “Social Network” 
f. MeSH:  “Psychosocial Support Systems” 
g. MeSH:  “Psychosocial Support System” 
h. MeSH:  “Support System, Psychosocial” 
i. MeSH:  “Support Systems, Psychosocial” 
j. MeSH:  “System, Psychosocial Support” 
k. MeSH:  “ Systems, Psychosocial Support” 
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The entry terms were beneficial in searching for articles that were classified under the 
relevant subject headings but were given different key word designations.  For each 
MeSH keyword all entry terms were included in the search and ‘*’ was used at the end of 
each term to capture key words and alternate suffixes. 
The search strategy proceeded in three stages.  First we narrowed our literature search by 
assessing the literature for quality of life in breast cancer patients. 
Literature search #1: [Breast Cancer] OR [Breast Neoplasm] AND [Quality of Life] OR 
[Life Qualities] OR [Life Quality]  
The literature in this search consisted of 320 items, most of which were not relevant to 
our study objectives.  Through this search key articles which discussed the use of quality 
of life instruments to assess treatment and survival in breast cancer patients and survivors 
were identified.  
Literature search #2: [Breast Cancer] OR [Breast Neoplasm] AND [Support, Social] 
OR [Social Networks] OR [Network, Social] OR [Networks, Social] OR [Social 
Network] OR [Psychosocial Support Systems] OR [Psychosocial Support System] OR 
[Support System, Psychosocial] OR [Support Systems, Psychosocial] OR [System, 
Psychosocial Support] OR [Systems, Psychosocial Support] 
Our second search generated 202569 items; the relevancy of literature accrued through 
this search was extremely variable.  To generate more precise literature, we included 
Breast Cancer as the major topic or focus of the article and Mesh terms related to ‘Social 
support’ in this search.  This approach yielded 1000 articles. The titles and abstracts of 
articles were then scanned for relevant literature. Relevant literature included critiques of 
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existing social support models for cancer patients, assessment of psychosocial distress 
among breast cancer patients, support and guidance to understand and choose treatment 
modalities, aspect of social networks useful to breast cancer patients and usefulness of 
social networks during the course of treatment and recovery in breast cancer survivors. 
Literature search #3: [Breast Cancer] OR [Breast Neoplasm] AND [Support, Social] 
OR [Social Networks] OR [Network, Social] OR [Networks, Social] OR [Social 
Network] OR [Psychosocial Support Systems] OR [Psychosocial Support System] OR 
[Support System, Psychosocial] OR [Support Systems, Psychosocial] OR [System, 
Psychosocial Support] OR [Systems, Psychosocial Support] AND [Quality of Life] OR 
[Life Qualities] OR [Life Quality]  
To concisely identify literature pertaining to our study objectives, we conducted a third 
literature search and identified 215 items.  These items were reviewed and 15 items 
relevant to our study objectives were identified.  Out of these 15 items, 7 items were 
identified as key articles for our research. Relevant items consisted of articles related to 
quality of life and social support in breast cancer survivors.  Additional literature was 
obtained by scanning the reference lists of key papers from the three literature searches. 
Health Care System in the United States 
The United States does not have a universal system of health insurance; however, 
approximately 84.7% of US citizens have some form of health insurance. Health 
insurance coverage is provided by employers (59.3%), purchased individually (8.9%), or 
provided by government programs (27.8%) (36).   Health care facilities in the US are 
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mostly owned as well as operated by the private sector but health care is provided by 
different private and public legal entities.  In the public sector, 60 – 65%, of health 
insurance coverage is available through government (federal and/or state) funded 
programs such as Medicare, Medicaid, TRICARE (Military Health System), the 
Children’s Health Insurance Program, Veterans Health Administration, Federal 
Employee Health Benefits Program and the Indian Health Service (37).  
 Medicaid is a US government funded health program for low income individuals and 
families. It is funded by the state and federal governments and managed by the states 
(37).  Each state operates its own Medicaid system which conforms to federal guidelines 
in order for the state to receive federal funds and grants (38). The Medicaid program is a 
“means-tested program.”  Means-tested programs entail determination of whether an 
individual or family is eligible for help from the government.  US citizens and permanent 
residents with limited assets and resources are eligible for Medicaid; however, poverty 
alone does not determine eligibility for Medicaid program unless they fall into certain 
designated eligibility groups.  Various eligibility categories for Medicaid determine who 
gets health care coverage through the program.  In addition to low-income, requirements 
such as assets, age and disability are considered for each category in the Medicaid 
program (38).  The Medicaid program in the state of California is called Medi-Cal.  It is 
administered by the California State Department of Health Care Services at the state level 
and the Centers for Medicare and Medicaid Services at the federal government level (37).   
In the US, low-income women who are diagnosed with breast or cervical cancer and 
require treatment but are uninsured or under-insured, are provided health coverage 
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through the Breast and Cervical Cancer Treatment Program (BCCTP).  BCCTP is a 
health coverage option in California, funded through Medicaid and legislated by the US 
federal government as a part of Breast and Cervical Cancer Prevention and Treatment Act 
of 2000.  In the state of California, uninsured, low-income women are enrolled in the 
BCCPT program through Medi-Cal and their treatments for breast cancer are covered 
through the BCCPT program (39).   
To be eligible for the Medi-Cal BCCPT in California, an applicant must be a resident of 
California, with an income that does not exceed 200% of the Federal Poverty Level 
(based on annual income and family size). Individuals may also be eligible if they have 
other health insurance coverage, as long as their premiums, co-payments and deductibles 
are expected to exceed $750 annually (39).    
Comparing US health system to the Canadian health system 
Every Canadian citizen and permanent resident is covered by publicly funded universal 
health care plan governed by the Canada Health Act (40).  In contrast, the US federal 
government does not guarantee universal health care to all its citizens; however, publicly 
funded health care programs help to provide for the elderly, disabled, children and the 
poor (38).   
A 2006 study, comparing US and Canadian access to health care in 2006, found more 
unmet medical needs among US residents as compared to their Canadian counterparts.  
US residents were less likely to have a regular medical doctor and twice more likely to 
forgo needed medicines (41).  Immigrants in both US and Canada face similar problems 
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accessing health care; a study comparing access to health care based on immigrant status 
in US and Canada concluded that immigrants in both countries have worse health care 
access as compared to non-immigrants (41).  Another study in 2010 showed that 
immigrants in Canada have better access to care as compared to immigrants in US; 
however, most of the differences were explained by differences in socio-economic status 
and insurance coverage across the two countries (42). 
In 2000, the World Health Organization (WHO) published a report ranking health care 
systems around the world based on health care outcome, funding for health care needs of 
the poor and health disparities due to income. Canada was ranked 30th and the US was 
ranked 37th in the WHO report (43).  Over all, Canadians have better health outcomes as 
compared to the US residents; observed incidence rates for various diseases including 
cancer are lower in Canada than in the US (44).   
According to Health Canada, the mortality rates due to cancers are similar in both US and 
Canada (45).  Survival rates for certain cancers such as breast cancer are higher in the US 
as compared to Canada (46). Survival rates for cancers in both countries are similar if 
screening processes especially for prostate and breast cancer are not taken into 
consideration (47).  Therefore, the Canadian and US health care systems are comparable 
in their delivery of cancer care based on similar mortality and survival data (46, 47).  The 
survival rates for cancer patients in Ontario are also similar to those of cancer survivors in 
different parts of the US (47).   
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Transdisciplinary framework for breast cancer care 
Health care systems and clinical practice including cancer care have advanced 
considerably during the last four decades (48, 49).  A focus on ‘transdisciplinary’ 
research in breast cancer patients has the potential of yielding valuable scientific 
information.  Hiatt and Breen presented a ‘transdisciplinary’ framework for breast cancer 
care, shown in Fig 1 (50).  According to Hiatt and Breen, in order to further advance 
cancer control research, the optimal approach would entail integration of the study of 
biological and physical nature of cancer and its clinical applications with the behavioural 
and social influences that cancer has on an individual (50).    
In the framework by Hiatt and Breen, different phases of life from pre-disease to 
mortality in breast cancer patients are presented as a cancer continuum on the horizontal 
axis in Fig 1.  Each phase is influenced by social and environmental factors. Four levels 
of analysis have been introduced into the framework. The introduction of each level of 
analysis is based on the need to highlight specific research approaches or pathways. The 
first level focuses on broad social conditions and policies; the second addresses the 
impact of healthcare systems on the cancer continuum; the third level looks at the 
behavioral and psychological factors; and the fourth level of analysis examines the 
biological mechanisms of carcinogenesis. According to Hiatt and Breen, disparities and 
burden of breast cancer may be reduced by introduction of interventions at any of these 
levels (50). 
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Figure 1. Hiatt and Breen’s framework for cancer care (50).  
   
 
Note: The framework  illustrates the relationship of levels of analysis with the types of 
interventions along the cancer continuum for e.g. healthcare systems are less likely to 
influence cancer incidence than mortality and are lightly shaded in the preclinical phase 
of the continuum. Social determinants are represented by dark shades throughout because 
these are more likely to influence breast cancer survivors throughout the cancer care 
continuum (50). 
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Although the framework appears to be simple and linear, the authors recognize that the 
clinical, biological and social interactions are more complex and multidimensional in 
reality (50).  Hiatt and Breen argue that social as well as behavioral and psychological 
determinants of breast cancer care, along with biological factors, play an important role 
all throughout the process of cancer care, including prevention and early detection.  
Health systems are mostly involved after the diagnosis.  Therefore, as shown in Fig 1, an 
intervention regarding social and psychological determinants of breast cancer can have 
considerable impact at every level of the disease such as prevention, early detection, 
treatment and quality of life. 
The modern perspective of clinical care and health care delivery entails improvement in 
quality of life as a corner stone for improving patients’ experience with the health care 
systems (48, 49).  Increased emphasis on improving patients’ experiences with the health 
care system has brought issues related to evaluation of quality of life to the forefront.   
Quality of life assessments are therefore, essential in determining the quality of health 
care received by breast cancer patients (51).    
Since the number of breast cancer survivors in North America is increasing every year (4, 
5, 6) and more women are surviving breast cancer for longer durations of time, it has 
become necessary to turn our focus on evaluating and improving quality of life among 
these women.  In order to understand the role of quality of life in cancer survivors, we 
must first understand the meaning of quality of life in the context of chronic illnesses 
such as breast cancer. 
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Quality of life in Breast Cancer Survivors 
According to the World Health Organization (WHO), health is defined as “a state of 
complete physical, mental, and social well-being and not merely the absence of disease.” 
The constitution of WHO puts a great deal of emphasis on the importance of measuring 
changes in HRQOL as well as improving HRQOL especially among chronically ill 
patients. The true estimate of well-being is not possible without measuring quality of life 
(52).  
The concept of quality of life related to well-being is not new; it dates back to the ancient 
Egyptian civilization (53).   Herodotus (450 BC) suggested that opulence of the tombs of 
valley of kings in Egypt and Thabes was an indication of the importance their society 
placed on quality of life even after death (53).  The supreme chief of medicine in 2800 
BC Egypt was named ‘Imhotep’ meaning “he who gives contentment.” Even in ancient 
Greece, the model of medical practice was based on a holistic approach where the 
patient’s wellbeing was determined by quantitative assessments of emotional reactions 
and interpersonal responses to their situation (53). 
Quality of life is a ubiquitous notion and can be interpreted in social, political, economic, 
philosophical and health related contexts, sometimes described as ‘complete life’.  
Merriam-Webster’s dictionary defines ‘quality’ as “degree of excellence” and life as “the 
sequence of physical and mental experiences that make up the existence of an 
individual.”    Scholarship on the concept of quality of life is vast and variable (54, 55). 
Aristotle’s (384 BC) idea of a good life consisted of ability to perform acts which led to 
internal and external good, resulting in individual happiness (56).  Throughout history 
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moral philosophers, historians and scientists have quibbled over the definition of quality 
of life.  In more recent times quality of life has become a distinct area of study especially 
in the fields of economics and medicine.  
In the field of medicine and health care delivery, health-related quality of life (HRQOL) 
serves as a measurement tool for success of care provided to the sick, especially those 
suffering from chronic illness.  Fallowfield (57) conceptualized the notion of quality of 
life in terms of health care and described this concept as follows: “quality of life is not a 
unitary concept, but rather a complex amalgam of satisfactory functioning in essentially 
four core or primary domains: psychological, social, occupational and physical.” Van 
Knippenberg and De Haes studied the meaning of quality of life in patients with chronic 
illness and especially focused on the meaning of quality of life in patients with cancer 
(58).  According to Van Knippenberg and De Haes, for those who had experienced 
prolonged illness, quality of life is described as possessing a state of wellbeing, 
satisfaction of needs, human values and quality of survival (58). 
 Cella and Tulsky offer a pragmatic approach to the understanding of HRQOL; they 
propose that quality of life is a comparison of one’s own health to an ideal state of 
physical and mental wellbeing (59).  Cella further argues that quality of life is a 
combination of patient perspective as subjective information and factual knowledge of 
physical well-being, functional ability, emotional well-being, and social well-being (60).  
Several approaches have been reviewed and subsequently used as objective assessment 
tools for quality of life (61, 62).  Calman in 1984, presented the ‘gap theory,’ which 
describes quality of life in terms of difference between patient’s ideal desires of the 
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standard of physical, mental and social wellbeing and the realistic expectation of what 
can be achieved in a given set of circumstances (61-63).  The psychological theory 
proposed by Kleinman (61, 62, 64) suggests that quality of life can be assessed by 
making a distinction between the actual vs. perceptual degree, severity and duration of 
illness.  Ware describes HRQOL in five multi-measure concepts: physical health, mental 
health, general health perceptions, social functioning and role functioning (65- 67).  
These five concepts are considered as a minimal standard for content validity of HRQOL 
(65 - 67). 
Ware et al. (67 -70) standardized the approach to measurement of HRQOL in patients 
with chronic disease with the development of their Medical Outcome Study Short form 
health survey with 20 questions (MOS SF-20).  The MOS short form health survey 
incorporates the concepts of physical health, mental health, general health perceptions, 
social functioning and role functioning.  The Medical Outcome Study Short form health 
survey with 36 questions (MOS SF36) was subsequently constructed to increase the 
comprehensiveness and improve precision of MOS SF-20 (67).  To improve the content 
validity of the Medical Outcome Study, Ware et al. included 3 more multi-measure 
concepts in the SF-36, which were: bodily pain, vitality and role limitations. These 
additional concepts were to be used to asses both physical and mental issues (67).   
Over the years HRQOL instruments have evolved to include cancer specific items and in 
some cases items more specific to quality of life issues in breast cancer patients.  
European Organization for Research and Treatment of Cancer Core Cancer Quality of 
Life Questionnaire (EORTC QLQ-BR23) is the most commonly used instruments used to 
assess HRQOL among breast cancer patients (71-75). Other instruments commonly used 
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are the Functional Assessment Chronic Illness Therapy General Questionnaire (FACIT – 
G) and its module for breast cancer the Functional Assessment Chronic Illness Therapy 
Breast Cancer Questionnaire (FACIT – B) (76 -77).  Montazeri in his review of health 
related HRQOL in breast cancer patients from 1974 to 2007 listed a number of validated 
instruments that have been used for assessment of HRQOL in breast cancer survivors in 
the last four decades (23).  The list of instruments used to assess HRQOL was divided in 
the following six categories by Montazeri (23): 
1. General instruments to assess HRQOL: these include the Short Form Health Survey 
(SF-36), Spitzer Quality of Life Index (QLI), Sickness Impact Profile (SIP), Ferrans 
and Powers Quality of Life Index (QLI). 
2. Cancer specific instruments to assess HRQOL: these are European Organization for 
Research and Treatment of Cancer Core quality of Life questionnaire (EORTC 
QLQ-C30), Functional Assessment of Chronic Illness Therapy General 
Questionnaire (FACIT-G) (formerly FACT), Functional Living Index-Cancer (FLI-
C) and Ferrans and Powers Quality of Life Index-Cancer (QLI-C). 
3. Breast cancer specific instruments to assess HRQOL: include European 
Organization for Research and Treatment of Cancer Breast Cancer Quality of Life 
Questionnaire (EORTC QLQ-BR23), Functional Assessment of Chronic Illness 
Therapy-Breast (FCIT-B), Breast Cancer Chemotherapy Questionnaire (BCQ) and 
The Satisfaction with Life Domains Scale for Breast Cancer (SLDS-BC). 
4. Psychological instruments to assess HRQOL: such as General Health 
Questionnaire-28 (GHQ-28),   Hospital Anxiety and Depression Scale (HADS), 
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Beck Depression Inventory (BDI), Center for Epidemiologic Studies Depression 
Scale (CES-D), State-Trait Anxiety Inventory (STAI), Profile Mood State (PMS), 
Mental Adjustment to Cancer Scale (MACS) and Psychosocial Adjustment to 
Illness Scale (PAIS). 
5. Symptom-related instruments to assess HRQOL: these measures are Functional 
Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Piper Fatigue Scale 
(PFS), Multidimensional Fatigue Inventory (MFI), Functional Assessment of 
Chronic Illness Therapy-B plus Arm Morbidity Subscale (FACIT-B ), Hot Flash 
Related Interference Scale (HFRDIS), Shoulder Disability Questionnaire (SDQ), 
Brief Pain Inventory (BPI), McGill Pain Questionnaire (MPQ), Memorial Symptom 
Assessment Scale (MSAS) and Rotterdam Symptom Checklist (RSC). 
6. Other instruments to assess HRQOL: include Functional Assessment of Chronic 
Illness Therapy-Spiritual (FACIT-SP), Body Image Scale (BIS), Body Image After 
Breast Cancer Questionnaire (BIBCQ), Watts Sexual Functioning Questionnaire 
(WSFQ), Life Satisfaction Questionnaire (LSQ) and Satisfaction With Life Scale 
(SWLS). 
The selection of instrument depends on the research question. For example FACIT-B 
would be a more suitable instrument to asses HRQOL in research related to breast cancer 
treatment, as compared to CES-D and BIBCQ, which may be more useful in studies 
related to assessment of psychological impact of breast cancer (23).  Instruments such as 
EORTC and FACIT examine HRQOL in cancer patients with specific questions designed 
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for potential responses unique to breast cancer patients.  Other instruments such as MOS 
SF-36 and QLI evaluate general HRQOL in patients with chronic illness (23, 78).   
Several studies in the recent past have used breast cancer specific HRQOL instruments 
such as EORTC QLQ-BR23 and FACIT-B (23, 72-76).  Studies suggest that HRQOL in 
breast cancer patients can be evaluated by using either a breast cancer specific instrument 
such as FACIT-B or a general instrument such as MOS SF-36 without compromising 
validity in both cases (76 - 78). The difference between breast cancer specific instruments 
and general instruments to assess HRQOL is that, in addition to HRQOL items, items 
specific to breast cancer care are also included in breast cancer specific instruments (67 – 
74).   
Breast cancer specific HRQOL instruments such as EORTC QLQ-BR23 and FACIT-B 
are designed to measure specific side effects of breast cancer treatment e.g. arm swelling, 
hormonal changes, breast oversensitivity; hence, these instruments are more useful in 
clinical trials comparing effects of treatment in breast cancer patients (78). Studies using 
breast cancer specific HRQOL instruments may be less precise in their assessment of 
effects of multidimensional predictors such as perceived social support on HRQOL (23).  
A general measure such as MOS SF-36 can be a more useful instrument in evaluating the 
effects of social support on HRQOL (23, 78). 
Ware and Sherbourne point out that evaluation of HRQOL requires the global appraisal 
of several concepts encompassing physical, mental and social well-being (67). The main 
reasons for using general measures of HRQOL is the ability of these measures to capture 
individual, temporal and cross cultural variations (78).  
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The perception of a particular aspect of quality of life and its relative importance (i.e. 
weight) may vary within individuals in addition to variation across individuals.  In 
addition, there may be temporal variations in the perception of an individual’s quality of 
life. For example, loss of appetite in a breast cancer patient can have several causes 
throughout the course of treatment. A patient’s loss of appetite can be attributed to 
toxicity due to chemotherapy, tumour activity, physical or mental co-morbidity such as 
diabetes or depression and may improve or get worse over time (78, 79).   
The other reason for global assessment of HRQOL is that the measures to assess HRQOL 
in breast cancer patients ought to be cross-culturally equivalent as there may be cultural 
variation in perception of disease and treatment sequelae and therefore, specific aspects 
may be perceived differently across the multiple cultural and social class groups (78-80).  
Determinants of Health Related Quality of life in Breast Cancer Patients 
Through our discussion regarding the definition of HRQOL it is clear that HRQOL is a 
complex concept based on an individual’s perception of physical, psychological and 
social wellbeing and satisfaction (57-58).  Due to the ubiquitous nature of HRQOL, the 
determinants of HRQOL consist of factors that affect every aspect of an individual’s life 
and depend on the type and duration of affliction.   
The literature on HRQOL in breast cancer survivors dates back to 1974 when the first 
article was published discussing subjective as well as objective assessment of HRQOL 
after adrenalectomy and chemotherapy in breast cancer patients with metastatic disease 
(23, 81). Since then, more than 600 articles have been published in peer reviewed 
journals, establishing associations between HRQOL and its determinants in women with 
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breast cancer (23).  A comprehensive review of the literature revealed several 
determinants of HRQOL in breast cancer survivors.  These determinants can be broadly 
classified into demographic factors, treatment related factors and psycho-social factors 
and are listed in Table 1.   
Some of the determinants of HRQOL in breast cancer survivors have a direct effect on 
HRQOL while others may have an indirect effect. For example a study in 2010 described 
Caucasian race, low BMI and higher education level as determinants of physical activity 
such as yoga in breast cancer patients (88); both BMI and physical activity also affect 
HRQOL in breast cancer survivors (89).   Ethnicity is another determinant which alone 
may not have a significant effect on HRQOL, however, spiritual and social practices 
combined among different ethnicities can have a significant impact on HRQOL (89).  
Demographic and treatment related factors that determine HRQOL have been extensively 
explored in the literature (23, 82-104) as shown in Table 1.  Psycho-social factors related 
to HRQOL have also been researched (92-104); however, social support as a determinant 
of HRQOL in breast cancer patients requires further attention and exploration (92). 
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Table 1: List of factors that determine Health Related Quality of Life (HRQOL) in 
breast cancer patients (23, 82 - 104). 
 Demographic factors  
 
Age  
              
                       
                                       
Basal Metabolic 
Rate  (BMI)                                   
                                                                
Menopause 
                                            
Income 
                               
Educational level 
           
             
Marital status 
 
 
Ethnicity 
 
 
Diet and exercise 
Age at the time of diagnosis is a significant predictor of 
HRQOL (82 -87). Women diagnosed with breast cancer after 
65 years of age showed significantly worse physical HRQOL 
whereas, those diagnosed between 45-65 years showed better 
physical HRQOL (86).  
Healthy-weight and/or overweight women with breast cancer 
reported significantly better physical HRQOL compared with 
their obese counterparts (89). 
HRQOL in Breast cancer survivors who had menopause was 
poor as a result of symptoms of menopause such as fatigue, 
pain etc. (83-85). 
Breast cancer survivors belonging to high-income groups have 
better ability to cope with disease and as a result have better 
physical and emotional HRQOL (23, 84, 85, 87 91). 
Breast cancer survivors with higher education level are able to 
understand and familiarize themselves with the disease and its 
possible outcome and therefore, have better emotional as well 
as physical HRQOL (23, 85, 91). 
Married breast cancer survivors show better HRQOL, however 
marriage or partnership already under stress can cause 
increased stress after breast cancer diagnosis. The added stress 
is a risk factor for deterioration in both physical and emotional 
HRQOL (92). 
African Americans and Latinas are reported to have better 
emotional HRQOL because of their spiritual practices (90). 
Most Caucasian women report better physical HRQOL because 
of increased engagement in physical activities (89). 
Cumulative effects of physical activity, vegetable consumption 
and smoking cessation had a positive effect ton HRQOL in 
women with breast cancer. (89).  Yoga improved emotional and 
 
  
 29     
 
physical HRQOL in women with breast cancer (88) 
 
 
 
Treatment related factors  
Stage of breast 
cancer 
                   
                                    
Type of 
Surgery 
                                                      
              
Chemotherapy 
 
 
                           
Radiation 
therapy 
         
              
Hormone 
replacement 
therapy 
 
             
 
 
Co-morbidity 
 
 
Treatment  
side effects 
Studies suggest that stage of the disease indirectly alters quality 
of life. Morbidity is related to later stage of breast cancer which 
leads to poor physical and emotional HRQOL. Stage of disease 
determines the treatment modality which also has an impact on 
HRQOL (23). 
Before breast reconstructive surgery became more common for 
breast cancer patients, mastectomy was related with poor 
emotional HRQOL due to poor body image issues related to 
mastectomy as compared to breast conserving surgery (23). 
Breast cancer chemotherapy has evolved due to data collected 
on HRQOL during clinical trials for chemotherapeutic agents.  
The effects of chemotherapy on HRQOL are variable and 
depend on the stage of disease. Women with more severe 
disease have reported very poor physical HRQOL after 
receiving chemotherapy (23). 
Radiation therapy is usually given in combination with surgery 
in breast cancer patients. Effects of radiation therapy on 
HRQOL are also observed in association with the surgical 
modality used to treat the patients. Physical side effects of 
radiation therapy such as arm swelling, chest pain and fatigue 
result in poor physical HRQOL (23). 
Literature on the association of hormone replacement therapy 
and HRQOL is limited.  Some studies suggest that side effects 
of anti-estrogens include hot flashes, weight gain, fatigue and 
depression. These side effects negatively affect quality of life in 
breast cancer patients (23). 
 
Physical and psychological co-morbidities have a negative 
effect on physical and emotional HRQOL in breast cancer 
patients (23). 
 
Physical HRQOL is compromised as a result of treatment side 
effects. Emotional HRQOL is compromised in women 
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undergoing mastectomy(23). 
  
Psycho-social  factors  
Uncertainty 
 
 
Stress 
 
Repression/ 
Denial 
                                              
 
Expression 
 
 
Spirituality 
 
 
 
 
Social support 
 
Supportive care 
Diagnosis of breast cancer can bring out feelings uncertainty in 
the surviving patient. Feelings of uncertainty impair emotional 
HRQOL in breast cancer survivors (94 -97).                                                                                                                                                               
A meta-analysis of psychosocial variables related to breast 
cancer found significant association between HRQOL in breast 
cancer patients and reported stressful life events (98).   
Various studies suggest that denial in women diagnosed with 
breast cancer deregulate the immune system and result in long 
term physical and psychological distress  resulting in 
deterioration in physical and emotional HRQOL (95, 97, 101, 
102). 
Emotional expression is the opposite of denial. Literature 
demonstrates a positive association between emotional 
expression and emotional HRQOL in breast cancer patients (99, 
100).                                                                
Spirituality is a determinant of HRQOL in breast cancer 
patients. It has been demonstrated that spirituality can enhance 
physical and psychological HRQOL. Levin reviewed more than 
250 published empirical studies on beneficial health effects of 
religious or spiritual practice. Because women with breast 
cancer have various stressors, their spiritual awareness acts as 
buffer against the effects of stress (104). 
 
Absence of social networks has been tied to decreased survival 
and rapid course of illness in breast cancer patients (103).  
Social support is a possible determinant of HRQOL; however, 
literature regarding the relationship between social support and 
HRQOL is scarce (92). 
Efficiency of ancillary care provided by the nursing staff, 
paramedics and social support staff is shown to have a positive 
relationship with HRQOL in breast cancer patients (23). 
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Social Support 
The term “social support” was coined in the middle of the 20th century but the concept of 
social support is not new.  Darwin declared humans to be social animals and attributed 
emotions such as sympathy, pleasure, love and satisfaction to this social animal (105).  
Survival of the human race according to Darwin was contingent on people’s ability to 
‘sympathetically’ co-exist with each other (105).   
Scientists have been studying the phenomenon of social integration and interdependence 
for a long time and various definitions have surfaced after the term ‘social support’ was 
coined in the 1970s (106).  Cobb in 1976 described social support as awareness by 
individuals that they are being cared for, loved, esteemed and valued.  It is also an 
acknowledgement that they belong to a network of communication and shared obligation 
(107, 108).   
According to Hupcey, the concept of social support is best defined in the context of its 
use; he stated (109), “Social support is a multi-faceted concept that has been difficult to 
conceptualise, define or measure. Although this concept has been extensively studied, 
there is little agreement among theoreticians and researchers as to its theoretical and 
operational definition. As a result, the concept remains fuzzy and almost anything that 
infers a social interaction may be considered social support.” 
Although the theoretical concept of social support may be ambiguous and complex, 
Hupcey concluded that it was possible to operationalize it for research by categorizing it 
into three facets (109).  The three operational facets of social support as described by 
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Hupcey are: 1) social network and social integration variables 2) received support and 3) 
perceived available support. 
Lugton (1977) also conceptualized social support as a multidimensional construct.  He 
opined that social support entailed counting and categorization of degree of individual’s 
social ties alongside a qualitative evaluation of those social ties (107).  Lugton divided 
social support into two categories: structural and functional support.  
Based on the work by Hupcey, Lugton and others in the field, social support can be 
conceptualized broadly as structural or received support and functional or perceived 
support. Categorization of social support is presented in Fig 2 and described below. 
Hupcey opined that measuring all the facets of social support would be impossible and 
fruitless in a single study and it is the task of researcher to identify which aspect of social 
support is important to study for a given context (109). Our study was designed to 
analyze the relationship between perceived social support and HRQOL; therefore we 
measured perceived or functional support among breast cancer survivors.  A discussion 
regarding the two categories of social support is given in the text below. 
Structural/ Received Social Support: 
Structural support quantifies and determines the interconnectedness of existing social 
relationships.  For example, marital status and the dynamics of marital relationship or 
number of friends and relations or degree of connectedness with friends and relations 
would be considered in the realm of structural support (110).  
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Figure 2. Organizational diagram for understanding social support  
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Hutchison studied the concept of structural social support from three perspectives: 
network structure, support functions and the nature of relationships (110).  Hutchison 
described social support in terms of quantity of one’s relationships. Structural support 
includes the number of interpersonal relationships and the extent to which there is 
interconnectedness between those relationships; however, the degree or quality of 
interconnected of relationships was not described by Hutchison and is not a part of 
structural support (110).  
Received support entails support measured in terms of numbers of individuals available 
to render support or in other words it is the same as structural support.  Received support 
according to Sherbourne et al., “is confounded with need and may not accurately reflect 
the amount of support that is available to a person” (30).   
Functional Support: 
Recent literature indicates that the concept of functional component of social support 
addresses the issues of quality vs. the quantity of support available (110-113). This 
approach emphasizes the functions of interpersonal relationship, such as emotional 
support, instrumental support, informational support and social companionship.  
Functional support is a perceptual paradigm described by Sherbourne and Stewart as 
perceived social support which refers to: “the degrees to which interpersonal 
relationships serve a particular function” (30). 
Cohen and Syme as well as Cohen and Wills concluded that an individual’s perception of 
social support is more important than the support received (111,112).  Sherbourne and 
Stewart argue that not having received support during a specific period of time does not 
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mean that there is no support available for such individual.  The concept of perceived 
social support or functional support was examined extensively by Stewart in the field of 
nursing, who based this concept of degree of relationships severing a purpose on various 
theories including coping theory, social comparison theory, social exchange theory, 
attribution theory, social learning theory and social competence (69).  
Role of Social support in breast cancer:  
Literature suggests that greater social support is associated with longer survival in women 
with localized or regional breast cancer (115, 116).  A prospective study looking at the 
effects of social context on rate of survival from breast cancer found that women with 
increased support, particularly outside the home, had significantly higher rates of survival 
at a four year follow-up (116).  Furthermore, absence of a social support network has 
been linked to not only a higher incidence of cancer and but also a more rapid course of 
illness including greater severity in physical as well as psychological morbidity (117). 
Measuring social support: 
Translating the theoretical concept of social support into research can be challenging.   
McDowell categorized and described the instruments used to measure social support 
(118), summarized in Table 2.  Most instruments presented in the table are self-
administered.  
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Table 2: Comparison of instruments measuring social support 
 
Instruments 
 
Advantages 
 
Disadvantages 
Social Relationship 
Scale (119) 
Used in the general population 
samples to measure individual`s 
network of social relationships and 
their perceived helpfulness in 
alleviating stress. 
Further testing in specific 
populations is required. 
Social Support 
Questionnaire (120) 
Quantifies availability of, and 
satisfaction with, social support. 
Does not cover 
informational or tangible 
support. 
RAND Social 
Health Battery (121) 
Records resources of social support 
and frequency of interactions. 
Does not rate the 
subjective experience of 
interactions. 
MOS Social Support 
Survey (30) 
Measures perceived social support 
in four categories. Main use in 
populations with chronic illness but 
can be used in general populations. 
Information about validity 
in general population is not 
yet available. 
 
Duke-UNC 
Functional Social 
Support 
Questionnaire  (122) 
Measures personal satisfaction with 
functional and affective aspects of 
social support. 
Mostly used in clinical 
practice. Concerns about 
convergent validity. 
Duke Social Support 
and Stress Scale 
(123) 
Rates the amount of support 
provided and/or stress caused by 
family and non-family 
relationships. 
Only used in family 
practice and family 
practice research.  Low 
retest reliability co-
efficient. 
Katz Adjustment 
Scales (124) 
Measures social adjustment of 
Psychiatric patients following 
treatment. 
Aspects of structural and 
functional support are not 
assessed. 
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Instruments 
 
Advantages 
 
Disadvantages 
Social Functioning 
Schedule (125) 
Assesses problems experienced in 
normal functioning. Was designed 
to evaluate treatment of neurotic 
patients. 
Neither measures the level 
of social support available 
to patients nor assesses the 
level of social functioning. 
 
Interview Schedule 
for Social 
Interaction (126) 
Availability and social quality of 
relationships in psychiatric patients. 
Administered by an expert 
and only for psychiatric 
patients. 
Social Adjustment 
Scale (127) 
Used as an outcome measure to 
evaluate drug treatment and 
psychotherapy in depressed 
patients. Has been used in other 
populations and healthy people. 
Measures social 
adjustment rather that 
social support. Difficulty 
in scoring sicker patients 
as well as recovering 
patients. 
Social 
Maladjustment 
Schedule (128) 
Used to measure social 
maladjustment in psychiatric 
patients, family practice and 
general population. 
Measures social 
maladjustment rather than 
support. Mainly used in 
UK and little evidence of 
reliability and validity has 
been published. 
Social Dysfunction 
Rating Scale (129) 
Assesses negative aspects of social 
adjustment. 
Measures social 
adjustment rather that 
social support. Scoring of 
the instrument is unclear 
and there is little evidence 
to support validity of the 
instrument. 
Structured & Scaled 
Interview to Assess 
Maladjustment 
(130) 
Clinical assessment of social role 
performance 
Assesses maladjustment 
and not social support. 
Mostly used in patients 
with psychiatric disorders. 
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Table 2 shows that most instruments measuring social support either focus on social 
adjustment aspect of support or social networking/ quantitative assessment of support i.e. 
structural support. MOS SS on the other hand only measures perceived social support. 
Perceived social support as described by Sherbourne et al., entails several constructs such 
as ability to perceive someone who is there to help with daily chores, knowledge that 
someone cares about you and a realization that someone loves you (30).  Sherbourne and 
Stewart constructed a model for perceived availability of social support (30).  The model 
incorporated the qualitative assessment of social ties or functional aspect of perceived 
social support and consisted of four dimensions of social support which are (30):  
1. Emotional /informational support: This means giving guidance or “appraisal 
support.” It involves presence of a support mechanism to provide appropriate 
guidance in response to any stress arising from the experience of disease. 
2. Affectionate support:  This dimension entails “attachment or affect”.  In other 
words perception of someone who cares for you, loves you, takes care of you and 
values you as an individual. 
3. Tangible support: Refers to the material, physical aid available to the individual.  
It involves existence of a reliable source of financial stability as well as 
availability of stable alliances. 
4. Positive social interaction: Takes into consideration the concept of 
companionship and social integration.  
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The Medical Outcome Study Social Support survey (MOS SS) incorporates these four 
dimensions in a comprehensive and independent tool for assessment of perceived 
availability of social support (30). The MOS SS distinguishes social support measures 
from physical and mental health measures; it also differentiates between social support 
and concepts such as loneliness and family functioning and has high reliability over time 
(30).   
Some breast cancer studies have used MOS SS due to its reliability over time and because 
of the instrument’s ability to differentiate between the concepts of perceived social 
support from physical and health measures (115, 131 - 132).   
Social support and HRQOL in women with breast cancer 
A diagnosis with cancer is a negative event causing distress (133). Diagnosis of breast 
cancer causes more distress than any other diagnosis and is stressful for women 
regardless of prognosis (95, 134). More than one third of the women diagnosed with 
breast cancer experience psychological distress, most commonly depression and anxiety 
(135). Studies suggest that severity of distress in breast cancer patients is associated with 
severity of the disease itself (106 -113, 133 – 135).  
Some articles on the other hand, suggest that cancer diagnosis is not a negative event 
(113, 135).  In fact, cancer diagnosis can be considered a “psychosocial transition” which 
according to Andrykowsi et al. is “an event with significant negative implications that 
can nevertheless cause individuals to restructure their attitudes, values, and behaviours, 
and thus can serve to trigger positive psychosocial change” (135).   
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 Since breast cancer is a complex illness with a significant psychosocial and physical 
burden, the treatment for breast cancer has become multifaceted.  In addition to surgery 
and systemic therapies, supportive care has become an integral part of treating breast 
cancer patients. Supportive care, according to Montazeri, encompasses nursing care, self-
care through diet and exercise, access to care, availability of care and also social support 
provided to breast cancer patients (23).  
Williams et al. analyzed the concept of social support in the context of HRQOL as it has 
evolved over the last few decades and identified two main models underpinning the 
concept of social support as it relates to HRQOL (133). The first model is the buffer 
model based on the works of Caplan and Casel and suggests that social support has a 
buffering or cushioning effect against life’s stressors and protects the individuals from 
physiological and psychological harms arising from stressful situations (136- 137). The 
second model was termed the main-effect or direct effect model. According to the main-
effect model, social support directly benefits the well-being of an individual by either 
fulfilling his/her basic needs or by emotionally inducing a positive effect on the immune 
system and thus, improve quality of life (133, 137 -139).  
We found extensive literature related to HRQOL and breast cancer since 1974, when the 
first article on the subject was published (23); however, published literature regarding 
HRQOL in breast cancer patients is mostly related to the effects of treatment and surgery 
in breast cancer patients, followed by psychological effect of cancer diagnosis and 
treatment on HRQOL (23).  The psychosocial factors that affect the HRQOL in breast 
cancer patients are listed in Table 1 (page 30).  Relationships between HRQOL and some 
psycho-social factors such as stress and supportive or ancillary care are already 
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established in literature; whereas, it is clear that more work is needed to understand the 
relationship between social support and HRQOL in women with breast cancer (23).   
Out of more than 600 publications on factors associated with HRQOL in breast cancer 
patients, Montazeri identified 5 articles published between 1974 and 2006, which were 
related to social support and HRQOL in these patients (23, 140 – 144). Our search 
yielded 10 new publications related to social support and quality of life in women with 
breast cancer from 2007 to 2011 (145 – 154).  Table 3 lists all the articles assessing 
relationship between social support and quality of life in breast cancer patients from 1974 
to 2011 (140 to 154).      
Lee published the first article addressing the issue of support and HRQOL in patients 
with breast cancer in 1997. A sample of 100 women who volunteered at a community 
outreach program and who had undergone mastectomy for breast cancer 14 years prior to 
his study were mailed the Ferrans and Powers Quality of Life-Cancer Version 
questionnaire to assess HRQOL. Ferrans and Powers QLI measures satisfaction and 
quality of life in five domains: health and functioning, psychological/spiritual domain, 
social and economic domain, and family (140).  No association between marital status 
and the number of type of relationships was found with HRQOL among women in the 
study group.  Thematic analysis revealed that sharing knowledge and providing 
emotional support was the main motivation to volunteer at the community outreach 
program (140). Lee concluded that providing social support outreach programs to women 
with breast cancer is necessary to help women in coping with psychological stress 
associated with breast cancer.   
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Table 3: List of articles related to social support and HRQOL in breast cancer patients   
(1974 – 2011) 
 
Authors 
(Reference) 
Year Key 
predictor/Intervention 
Results/Conclusions 
Lee (140) 1997 Social support (Reach 
to Recovery 
programme) 
Social support plays a vital role 
in promoting overall HRQOL. 
Sammarco (141) 2001 Perceived social 
support and uncertainty 
in younger breast 
cancer survivors 
Significant positive correlation 
between perceived social 
support and HRQOL, and 
significant negative correlation 
between uncertainty and 
HRQOL. 
Michael et al. 
(142) 
2002 Social networks Pre-diagnosis level of social 
integration was important 
factor in future HRQOL, and 
explains more of the variance 
than treatment or tumour 
characteristics. 
Manning-Walsh 
(143) 
2005 Relationships between 
personal and religious 
support and symptom 
distress and HRQOL 
Personal support was 
positively related to HRQOL. 
Sutton and Erlen 
(144) 
2006 Mutual dyadic support 
intervention 
Most dyadic relationships were 
supportive and improved 
emotional HRQOL. 
Danhauer et al. 
(145) 
2007 Collaborative, wellness- 
based group support for  
young women 
No significant improvement on 
HRQOL , study identified 
areas for potential 
improvement in the program. 
Kissane et al. 
(146) 
2007 Supportive expressive 
group therapy  (SEGT) 
for women with 
metastatic disease 
SEGT improved HRQOL 
including treatment and 
protection against depression. 
Ogce et al. (147) 2007 Social support in 
Turkish women 
Social support improves 
HRQOL, family stressors have 
negative effects on HRQOL. 
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Authors 
(Reference) 
Year Key predictor/Intervention Results/Conclusions 
 
Filazoglu et al. 
(148) 
 
2008 
 
Role of social support in 
Turkish women 
 
Coping and social 
support have a positive 
effect on HRQOL. 
Lim et al. (149) 2008 Social support in Korean 
women 
Direct positive effect of 
social support on 
HRQOL. 
Nápoles-Springer 
et al. (150) 
2009 Peer support counselling  Creating psychosocial 
programs with input from 
survivors and advocates 
who have similar self-
identities to patients 
improve HRQOL.  
Menesses et al.  
(151) 
2009 Psycho educational support Positive relation of 
Psycho educational 
support and HRQOL 
Sammarco et al. 
(152) 
2010 Perceived social support in 
Latinas and Caucasians 
Perceived social support 
has an association with 
HRQOL and educational 
interventions should be 
mindful of ethnicity, 
cultural values and 
education level. 
Marylin et al. 
(153) 
2010 Social support immediately 
post diagnosis 
Positive relation of social 
support and HRQOL, 
immediately post 
diagnosis. 
Salonen P et al. 
(154) 
2011 Face to face support and 
quality of life  
Short term face to face 
support improves 
HRQOL in women with 
breast cancer. 
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Samarco analyzed the relationship between perceived social support and HRQOL and 
found a significant positive correlation between perceived social support and quality of 
life, a positive correlation between support and network size and between network size 
and socio-economic domain of QOL index. The study population consisted of younger 
women (≤ 50 years) with breast cancer. Social support questionnaire (SSQ) was used to 
measure social support and Ferrans and Powers Quality of Life-Cancer Version 
questionnaire was used to assess HRQOL for this study (141). The SSQ is a brief and 
easy to administer instrument which measures availability of social networks as well as 
some aspects of perceived social support; however, the instrument lacks the ability to 
comprehensively assess perceived social support as informational or tangible support are 
not measured using SSQ (120). No association between physical or mental HRQOL and 
social networks size was reported in the study.   
In another study in 2010, Sammarco et al. looked at the effects of perceived social 
support on HRQOL using among Latinas and compared the effects with Caucasian 
women with breast cancer. Instruments used in the previous study (141) were used in this 
study as well. Caucasians had a higher perception of social support in the study (152).  
However, SSQ does not measure tangible and informational support (120). Cultural 
values and higher education showed a positive impact on HRQOL (152). 
Michael et al. and Manning assessed social support as social networks and number of 
family members available to provide support. Both these studies evaluated the impact of 
structural support on HRQOL in women with breast cancer (142, 143). Michael et al. 
administered detailed questions related to treatment and HRQOL to 708 women 
diagnosed with breast cancer over a period of 4 years.  Two instruments, MOS SF-36 and 
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CAncer Rehabilitation Evaluation System-Short Form (CARES-SF) were used to assess 
HRQOL. The modified Berkman–Syme Social Network Index (SNI) was used to 
measure frequency of involvement with social ties (which could range from intimate 
family and friends to extended community) (156). Michael et al. found socially isolated 
breast cancer patients scored lower in role functioning, vitality and physical functioning 
aspects of HRQOL when compared with breast cancer patients who were socially more 
integrated (142). 
 Manning looked at the effects of social support such as family members and friends 
available to help women with breast cancer on symptom distress as a mediator for 
HRQOL. Mean age of the 100 Caucasian women participating in the study was 46 years 
and they were administered FACIT-B questionnaire to assess HRQOL. According to 
Manning, having more social support reduced the negative aspects of symptom distress 
and positively affected HRQOL in women who had undergone surgery for breast cancer 
(143).  
Sutton and Erelen used qualitative methodology to analyze the impact of social 
interactions between newly diagnosed stage I and II breast cancer patients and survivors 
on quality of life and interpersonal relationship of the participants in the study. Dyadic 
pairs consisted of 31 women newly diagnosed with breast cancer pairing with 31 
survivors of breast cancer.  Their biweekly interactions were logged for 8 weeks. 
Thematic content analysis of the log books was used to analyze the data for this study. 
Among the various themes emerging from the study, emotional support and focus on 
health and functioning were important considerations for women with newly diagnosed 
breast cancer. This study generated important knowledge related to HRQOL concerns 
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among women newly diagnosed with breast cancer and also highlighted the importance 
of supportive care for women with breast cancer.  Because this study only used thematic 
analysis, no causal association could be established between dyadic support and HRQOL 
and the authors suggested that future quantitative studies are required to evaluate such 
associations (144). 
Another study which evaluated the impact of having a peer based support system for 
women with breast cancer was published by Danhauer et al. in 2007(145). This study 
evaluated the effectiveness of a peer based intervention program introduced for women 
with breast cancer. The intervention program entailed having a group of peers diagnosed 
with breast cancer involved in various activities such as discussions regarding the disease 
process and relaxing exercises. After participating in the intervention program, women 
who had consented to participate in the study were sent questionnaires to assess: HRQOL 
(FACIT G and FACIT B), depression (Center for Epidemiologic Studies–Depression 
Scale), current affect (Positive and Negative Affect Schedule), satisfaction with one’s life 
as a whole (Satisfaction with Life Scale) and program evaluation.  Women diagnosed 
with breast cancer reported improvement by seven points on HRQOL after participating 
in the intervention program. This improvement according to the authors was clinically 
significant; however, it was not found to be statistically significant. The main purpose of 
the study was to assess the feasibility of collaboration between academic medical centre, 
regional cancer centre and community based cancer centre.  Although, Danhauer et al. 
did not find a significant relationship between peer social support group activities and 
HRQOL, the women found some discussions, such as those related to coping after the 
news of diagnosis, to be very useful (145).   
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Kissane et al. used a randomized clinical trial to study the impact of supportive 
expressive group therapy (SEGT) in women with metastatic breast cancer. Women who 
had been diagnosed with metastatic breast cancer were randomized into intervention 
group which received SEGT and control group which did not receive SEGT, both groups 
received three sessions of regular relaxation therapy. Group therapy consisted 90-min 
sessions of SEGT every week. Women were enrolled for at least one year in the study. 
The aim of these sessions was to improve relationships with family, friends and 
physicians, create a new network of support and foster coping skills.  Kissane et al. 
concluded that SEGT for women with metastatic breast cancer improved social 
functioning and reduced depression in women with metastatic breast cancer (146).  
Another qualitative study evaluating the effects of peer support counselling interventions 
in breast cancer patients was conducted by Nàpoles-Springer et al.  They identified and 
interviewed 89 breast cancer patients, 29 Spanish speaking breast cancer survivors and 17 
culturally competent advocates for Latinos with cancer and conducted interviews. The 
results of the study indicated a need for supportive interventions which should begin 
close to diagnosis with breast cancer and psycho social programs with input from 
survivors.  The authors believed that early psychosocial interventions are likely to 
improve HRQOL in diverse and underserved populations.  This study provides useful 
information about the needs of underserved women with breast cancer and identifies 
steps that are required to improve HRQOL in these populations (150). 
Menesses et al. evaluated the impact of psycho educational supportive intervention 
(breast cancer education intervention (BCEI)) on HRQOL in women with breast cancer 
from rural US.  A convenience sample of 53 women with breast cancer were randomized 
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into experimental group with 27 participants and wait-control groups with 26 
participants.  The experimental group had more face to face educational support in the 
first 6 months as compared to wait-control group.  In the 7th month, there was no activity 
for the experimental group, while the wait control group received educational support 
through telephone.  Overall quality of life using Quality of Life Breast Cancer Survivors 
Tool was used as an outcome measure.  Menesses et al. concluded that BCEI improved 
HRQOL in women with breast cancer in rural US; however, a need for better delivery 
system for educational sessions to women with breast cancer living in rural areas was 
identified (146).   
More recently Salonen et al. evaluated an intervention of face to face social support in 
breast cancer patients.  Women in the intervention group of the study were provided with 
face to face social support and they reported fewer arm symptoms and (clinically) better 
sexual functioning.  Women diagnosed with breast cancer who were not provided with 
face to face social support intervention reported poor HRQOL.  Salonen et al. argued that 
breast cancer patients should be offered systematic support and education tailored to their 
individual needs (154). 
 A study involving 101 women undergoing treatment for breast cancer in Turkey looked 
at the impact of perceived social support using Multidimensional Scale of Perceived 
Social Support (MSPSS) on HRQOL measured by using Rotterdam Symptom Control 
List (RSCL) and Karnofski Performance Status Scale (KPSS). Those who had more 
family support reported better psychological and global quality of life. RSCL measures 
the HRQOL relevant to symptoms of cancer while KPSS is limited in its capacity to 
appraise global HRQOL (147).   
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Another study from Turkey used a cross-sectional design to evaluate the impact of 
perceived social support on HRQOL. MPSS was used to measure perceived social 
support, while SF-36 was used to assess HRQOL.  Multiple regression analyses indicated 
that social support was significantly associated with both physical and mental HRQOL 
(148). 
A study comparing Korean-American women with breast or gynecological cancer to 
Korean women with breast or gynecological cancer was published in 2008.  The main 
purpose of the study was to assess the pathways in social support that could improve 
HRQOL in these women. Quality of Life-Cancer Survivor (QOL-CS) was used for the 
assessment of QOL. MOS SS was used to assess perceived social support; in addition, 
structural support was measured using SNI. The researchers concluded that perceived 
social support directly influenced HRQOL and social networks either directly or 
indirectly influenced HRQOL in both Korean-American and Korean women with breast 
or gynecological cancer (149). 
Marylin et al. used a cohort of 950 women to study the impact of perceived social support 
measured by MOS SS on HRQOL which was measured using the FACT-B. The 
researchers found a positive association between perceived social support and HRQOL 
immediately after diagnosis of breast cancer (153). 
Gaps in the literature  
Despite the significance of social support to both psychological and physical wellbeing, 
Peters-Golden found that only half of the women diagnosed with breast cancer feel that 
they have necessary social support (117). From our discussion regarding the prevalence 
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of breast cancer and effects of social support on quality of life in women with breast 
cancer, it is clear that social support as a variable deserves attention in patients with 
breast cancer.  
Structural or received support only measures the number of individuals present in the 
breast cancer survivor’s life. It does not measure the degree of usefulness of available 
support. Perceived functional support is a measure of degree of usefulness of support 
(30).  In addition, the support structure (or received support) can vary over time for 
patients suffering from chronic illness such as breast cancer. Sherbourne and Stewart 
pointed out that not having received support during a specific period of time does not 
mean that there is no support available for such individual (30).  Therefore, it is important 
to evaluate perception of social support among women with breast cancer in order to 
understand the presence and degree of usefulness of support available to these women. 
Most studies looking at the relationship between social support and HRQOL listed in 
Table 3 either evaluated the structural aspect of social support i.e. number of social 
networks, number of family members of friends available to provide support (142, 143, 
149) or social support intervention programs (140, 144, 145146, 150, 151, 154).  Very 
few studies listed in Table 3 are evaluating the impact of ‘perceived social support’ on 
HRQOL (141, 147, 148, 149, 152).  
Although, Lee’s (140) conclusion supported the positive role of social support in terms of 
improving HQOL in women with breast cancer, these conclusions were based on a 
qualitative assessment of motivation to volunteer at an outreach program.  The study did 
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not address the issue of perception of social support and its effects on HRQOL in breast 
cancer patients. 
Similarly Sutton and Erlen as well as Nápoles-Springer et al. provided evidence that 
women diagnosed with breast cancer considered early psychosocial intervention to be 
beneficial to their HRQOL (144, 150).  These studies also relied on qualitative 
assessment of patients’ perception of social support and no association between perceived 
social support and HRQOL could be established in these studies. 
MOS SS was used as a measure for perceived social support in only 2 of the 15 studies 
listed in Table 3 (149, 153).  Sammarco used SSQ (141, 152) as a measure for perceived 
social support.  SSQ is limited in its appraisal of perceived social support as it lacks the 
ability to measure two (informational and tangible support) of the four domains of 
perceived social support measured by MOS SS.  The two Turkish studies used MSPSS as 
measure for perceived social support (147, 148).  The MSPSS is based on perceived 
social support in context of three sources of support which are family, friends or 
significant other (157).  Only 2 studies listed in Table 3, used MOS SF-36 to assess 
HRQOL in women with breast cancer (142, 148). Some studies used other measures for 
global assessment of HRQOL such as Ferrans and Powers QLI (140, 141, 152). Other 
studies used breast cancer specific instruments such as FACIT-B and symptom related 
instruments such as RCS.  
Received support only assesses amount of visible support and unlike perceived social 
support, it does not take into account the usefulness of that support for the affected 
individual. Analysing perceived social support would therefore, yield useful information 
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about social support from patients’ perspective. MOS SS has been used as a measure of 
perceived social support and MOS SF-36 as a measure of HRQOL; to date, the 
relationship between perceived social support and HRQOL in women with breast has not 
been explored using both MOS SS and MOS SF-36 as predictor and outcome variables 
respectively in the same study. 
Studies suggest that low SES is an indicator for increased mortality and morbidity in 
women with breast cancer (1-5).  A qualitative study among breast cancer survivors in 
North America showed that breast cancer survivors from low SES reported poor 
perception of social support as well as HRQOL (150).  A quantitative assessment of the 
effects of social support on HRQOL among low SES breast cancer survivors is the next 
step in further exploring this relationship. 
Our literature review indicates that no quantitative study to date has reported the effects 
of perceived social support on HRQOL among low SES women in North America and 
more work is required to explore this relationship. Furthermore, this relationship has not 
been assessed in low SES women with breast cancer in years following their diagnosis 
and subsequent treatment. Our aim is to understand the relationship between perceived 
social support after 18 months of diagnosis and HRQOL after 3 years of diagnosis in 
women with breast cancer, with an objective to: 
1. Determine the association between perceived social support and physical HRQOL 
among low SES women diagnosed with breast cancer. 
2. Determine the association between perceived social support and emotional 
HRQOL in the same population of women. 
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Chapter 3 
Materials and Methods 
Objectives: 
Few studies have looked at the association between perceived social support and HRQOL 
and none has examined this relationship in low SES women with breast cancer. Our study 
aims to fill the gap in literature by identifying the relationship between perceived social 
support and HRQOL among low SES women in North America over a period of 3 years. 
Our research will specifically: 
3. Determine the association between perceived social support and physical HRQOL 
among low SES women diagnosed with breast cancer. 
4. Determine the association between perceived social support and emotional 
HRQOL in the same population of women. 
Original study: 
Our study uses secondary data from a previous study designed to assess determinants of 
breast cancer treatment in an underserved population.  The aim of the original study was 
to obtain empirical evidence for improving health care and creating new interventions for 
underserved breast cancer survivors.  The study followed a cohort of 921 underserved 
women enrolled in the BCCTP (Breast and Cervical Cancer Treatment Program) in 
California and individual and systems-level determinants of breast cancer treatment were 
analyzed.   
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Data were collected through patient surveys and medical chart abstraction over a period 
of three years.  The baseline study surveyed participants at 6 months after breast cancer 
diagnosis, followed by surveys at 18 months and then 3 years after diagnosis (160).   
 The purpose of the surveys was to study the 1) Determinants of breast cancer care and 2) 
Determinants of survivorship in breast cancer patients.  Determinants of breast cancer 
care were categorized as individual (e.g. stage of disease, co-morbidities, and marital 
status), inter-personal (e.g. relationship between patient and clinical staff) and system-
level (e.g., benefits, setting of care, and access to health care).  In addition, individual, 
inter-personal and system-level determinants of survivorship (health status, functioning, 
and quality of life) were also assessed in the original study.  Medical records were 
extracted at 18 months after diagnosis to determine details of breast cancer treatment. 
Study Population 
The study population consisted of breast cancer patients who were newly diagnosed and 
spoke English or Spanish and resided in California.  These women were enrolled in 
Medi-Cal’s (California’s Medicaid) BCCPT program.  BCCPT is a health coverage 
option in California, funded through Medicaid and legislated by the U.S. federal 
government as a part of Breast and Cervical Cancer Prevention and Treatment Act of 
2000.  Women who were diagnosed with breast or cervical cancer and require treatment 
but are uninsured or under-insured, and have low-income are provided health coverage 
through BCCTP (37, 38). 
The original study was approved by the UCLA Human Subjects Protection Committee 
and the California State Department of Health Services Human Subject Protection 
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Committee.  The patient survey responses were anonymous and patient identities were 
coded, therefore, no information which could identify or report on individual participants 
of the study was available for this thesis.  In accordance with the TCPS guidelines 3.4 
and 3.5, in the absence of identifiable information, we proceeded with secondary data 
analysis for this thesis based on ethics approval in California (158, 159). 
Eligibility criteria and selection of participants 
Women who were 18 years or older and had definitively been diagnosed with breast 
cancer for the first time, were able to speak English or Spanish, living in California and 
receiving care through BCCPT were eligible to participate in the original study.  Some 
women were newly diagnosed with breast cancer but were excluded from the original 
study because they: 1) could not speak either English or Spanish 2) had been diagnosed 
with breast cancer for more than 6 months at the time of baseline interview 3) were 
misdiagnosed 4) were previously diagnosed with breast cancer 5) were currently 
diagnosed or undergoing treatment for other cancer 6) had passed away before the 
baseline survey was conducted, 7) had cognitive challenges or 8) did not receive BCCPT 
benefits. 
Data collection 
Participants in the original study were identified by the California Department of Health 
Services as women who had been diagnosed with breast cancer for the first time in the 
last six months prior to their recruitment in the study.   The identified participants were 
invited by mail to take part in a one hour telephone survey.  Out of the 1869 potential 
participants, 239 refused, 360 were ineligible and 234 could not be contacted. Nine 
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hundred and twenty one of the 1508 who were eligible, scheduled an interview and 
completed the baseline telephone survey from March 2003 through August 2005. The 
response rate for the baseline survey was 61.1%. The study recruitment flow chart for our 
study is presented in Fig 3. Details of study recruitment for this data set have been 
published elsewhere (160) and are presented in Appendix A.  
Data for the original study were collected 6, 18 and 36 months after diagnosis with breast 
cancer.  The data were collected at the time of regular follow up for breast cancer 
patients, consistent with the American Society of Clinical Oncology (ASCO) guidelines 
(which recommend a physical examination by a clinician every 3-6 months for the first 
year after breast cancer diagnosis, then every 6-12 months for the next 2 years, and then 
yearly after that) (17).  Stage of disease and confirmation of type of treatment received by 
the patient were ascertained by reviewing the medical records at 18 months after breast 
cancer diagnosis.   
The survey interviews were conducted by trained interviewers. Data related to 
demographic characteristics, diagnostic options and delay, initial cancer care, barriers to 
cancer care, satisfaction with initial cancer care, medical decision making, co-morbidity, 
patients’ knowledge and self-efficacy, health beliefs, acculturation and number of people 
available to provide support were collected at baseline. 
The women were contacted for a second survey from September 2004 through October 
2006, 18 months after their breast cancer diagnosis.  Out of the 921 women who had 
completed the first survey, 798 scheduled and completed the second survey conducted 
again via telephone interview.  
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Figure 3:  Our study recruitment flow chart. 
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At the second interview, information about follow up treatment, barriers to accessing 
health care, satisfaction with treatment, side effects to treatment, quality of life and 
perception of available social support was gathered. 
The third survey, another one hour interview, was carried out from May 2005 through 
July 2008, 3 years after the breast cancer diagnosis and 666 women participated in this 
survey.  Among the women who dropped out of the study, the majority were those who 
could not be contacted due to change of contact information, some had died and others 
had refused to be contacted for further studies.  Questions related to recurrence, follow up 
questions on treatment, side effects, access to care and quality of life were asked in the 
third survey. A time line of data collection is given in Appendix B.  
For our study, we used a cross-sectional study design using the cohort of low SES women 
18 years and older, living in California and newly diagnosed with breast cancer who 
participated in the original study.  Women who had been interviewed for all three surveys 
were selected for analyses in our study.  Perceived social support and other covariates 
were collected at the second survey which was at 18 months after breast cancer diagnosis 
and HRQOL was measured 36 months after diagnosis with breast cancer.  The total 
number of women participating in our study was 634. 
Conceptual framework  
The conceptual framework for our study is based on the Pearlin’s stress process model 
(161 – 163) and derived from literature review of variables associated with HRQOL and 
breast cancer care (Table 1) as well as the contextual model for breast cancer care 
described by Ashing Giwa (170).  Our conceptual model is presented in Fig 4.  
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The stress model evaluates the process by which stressors are able to exert their health 
effects over time. Pearlin’s stress model is derived from social stress theory as well as 
literature pertaining to medical sociology (162, 163).  It has been extensively used in 
various epidemiological studies, especially in evaluations of psychological distress and 
role of care givers and social networks among breast cancer patients (164 – 167).  Turner 
and Lloyd analysed the stress processes as described by Pearlin.  They concluded that 
through the use of the stress models, researchers can identify the interrelationship 
between acute or chronic stressful life experiences and social as well as personal 
relationships which may have an impact on health outcomes over time.  This can lead to 
identification of targets for intervention to alleviate or reduce the negative impact of 
stressors and consequently improve quality of life (168).   
For life events and chronic strains such as those observed in women with breast cancer, 
Pearlin et al. described two mechanisms through which stress is manifested.  The first 
mechanism is the appearance of a stressful life event at a discrete point.  The second 
mechanism is the slow and persistent presence of strain which generates either a new 
strain or magnifies existing strains (161).    
The initial stressor is called the ‘primary stressor’, which in our model is being diagnosed 
with and living with breast cancer.  The ‘secondary stressors’ (in our model include 
individual and systems-related factors) are the ones which follow the primary stressor and 
contribute to the duration and level of stress in breast cancer survivors.  For a woman 
with breast cancer, the primary and secondary stressors appear in a temporal sequence as 
presented in Fig 4, which depicts a pathway between our exposure and outcome variables 
(169).  
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Figure 4: Conceptual framework for our study.  
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Perceived social support is known to have a buffering effect against stress in general 
population and those suffering with cancer in particular (104, 133, 136, 137).  Therefore, 
in our conceptual model we propose that perception of social support in the years 
following diagnosis with breast cancer has an impact on the future stress outcomes such 
as physical and mental HRQOL. 
Pearlin also described the process of ‘stress proliferation’ which explains the 
interconnectedness of hardships on an individual over time.  The process of ‘stress 
proliferation’ is two fold: first, the life course itself has an impact on an individual for, 
e.g., those belonging to lower SES have greater hardships in life compared to those 
belonging to higher SES; second, the addition of burdens of life, which Pearlin terms as 
‘allostatic load’. Greater the allostatic load, the more difficult it is for bodily systems to 
work at optimal capacity.  Those already disadvantaged during their life course (e.g. 
belonging to lower SES), suffer from greater allostatic load which result in poor 
outcomes (162). 
In addition to the hypothesized relationship between effects of perceived social support 
on HRQOL in women with breast cancer, several factors serving as secondary stressors 
can affect both the exposure and outcome and as a result have an impact on the exposure 
and outcome. In our model these factors are broadly categorized into ‘individual-related 
factors’ and ‘systems-related factors’.  
 A list of factors that affect HRQOL in women with breast cancer is given in Table 1 
(pages 28 -30).  These factors serve as individual-related factors in the causal pathway 
between perceived social support and HRQOL in women diagnosed with breast cancer. 
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The systems-related factors in our conceptual model are based on contextual framework 
presented by Ashing-Giwa (170).  Ashing-Giwa studied the socio-cultural determinants 
of quality of life in minorities such as Latina and Asian Americans and presented a 
contextual model of the relationship HRQOL and determinants of HRQOL.  Ashing-
Giwa’s model consists of a framework to investigate areas of health disparities and risk 
factors for poor outcomes in HRQOL research with cancer survivors.  This contextual 
HRQOL theoretical framework includes cultural and socio-ecological dimensions and 
explains that in addition to individual-related factors, factors such as relationship with 
hospital and staff, life stressors etc. can also have an impact on cancer care and outcomes 
(170). We incorporated the contextual model described by Ashing-Giwa into our model 
by including the systems-related factors in our causal pathway.  
The stress outcomes which in our model are physical and emotional HRQOL in women 
with breast cancer are a consequence of combination of all the components in our model.  
The impact of perceived social support on HRQOL is confounded by various factors 
hypothesized in our conceptual model.  There is ample evidence cited in the literature to 
support our hypothesis (23, 82-170).  Thus, the model presented in Fig 4 adequately 
describes the temporal causal relationship between perceived social support in women 
with breast cancer and their HRQOL. 
Measures used in our study  
Variables used in our study were collected at different time points, details of which are 
given in Appendix B.  We used the conceptual framework presented in Fig 4 to select the 
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variables from the original study to be used in our analysis.  Details of the variables used 
in our study are given in the sections below. 
The unit of analysis for our study was a woman who was a breast cancer survivor. A 
breast cancer survivor for this study was defined as ‘a woman who had been diagnosed 
with breast cancer 6 months prior to the baseline survey and had undergone treatment for 
breast cancer and is currently undergoing treatment, recurrence or convalescence.’  
The central component of this study was evaluating the impact of perceived social 
support on HRQOL among breast cancer survivors.  According to the Canadian 
guidelines for breast cancer care, psycho- social evaluation and interventions in breast 
cancer survivors are to be explored after one year of cancer diagnosis (16, 17). The time 
line for variables collected in the original study is given in Appendix B.  Our key 
predictor variable of interest was perceived social support.  Other predictor variables 
relevant to our study are highlighted in Appendix B.  All predictor variables were 
collected at 18 months after breast cancer diagnosis except for age, menopause, ethnicity 
and education level, which were collected at baseline. Our outcome variables, physical 
and emotional HRQOL were collected at 36 months after breast cancer diagnosis.  
Primary Outcome Variables: 
The primary outcomes of interest in this study were physical and emotional HRQOL, 
measured using Medical Outcomes Study Short Form-36 (MOS SF-36). The SF-36 is a 
generic measure that assesses the eight most important health concepts which represent 
basic human values and have relevance to functional status and wellbeing (67).  These 
eight health concepts also known as sub-scales of SF-36 and are: 1) General health 2) 
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Physical functioning 3) Vitality/Energy 4) Body pain 5) Role limitation due to physical 
functioning 6) Role limitation due to mental functioning 7) Emotional wellbeing and   8) 
Social functioning 
The SF-36 is a reliable instrument with median reliability coefficient for each health 
concept sub-scale equalling or exceeding 0.8, except for the social functioning scale, 
which has a median reliability coefficient of 0.76 (68). The SF-36 has been validated as a 
tool for assessment of HRQOL in the general US population (68, 70). It has also been 
translated and validated in Spanish (68).  The SF-36 survey is shown in Appendix C.  
We transformed the SF-36 from survey items into to component summary scores 
representing physical and emotional health.  Thirty six questions known as items were 
categorized into 8 sub-scales.  Thirty five items from the survey were converted into 8 
sub-scales with scores between 0 and 100; 0 being the worst outcome and 100 being the 
best outcome for HRQOL. The 36th item in the survey measured the transition of health 
over a period of one year (171); the last item did not relate to our study question and was 
not used in our analysis. 
Physical and mental component summary scores were generated from the 8 sub-scales. 
The physical functioning, physical role limitation and body pain scales contribute to the 
scoring of the Physical Component Summary (PCS) score (172) while emotional health, 
emotional role limitation and social functioning scales contribute to the scoring of the 
Mental Component Summary (MCS) score. General health, body pain and vitality/energy 
contribute to both PCS and MCS (172).  The distribution of SF-36 items and sub-scales 
in relation to the physical and mental component summary scores is presented in Fig 5. 
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Fig 5: HRQOL using Medical Outcome Study Short Form-36 (65 -68). 
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Converting SF-36 items to sub-scales  
Responses to the SF-36 survey were scored according to the standardized scoring 
algorithm described by Ware et al. (171), shown in Appendix D.  Conversion of SF-36 
items to scales was a three step process: 
1) Item recoding:  we recoded items according to pre-specified algorithm (Appendix 
D).   
2) Items were then summed and transformed into raw scale scores. 
3) Raw scale scores were transformed to a score of 0 -100, using the following 
transformation formula: 
Transformed Scale = [(Actual score – Lowest possible raw score) / Possible raw score 
range] × 100 
Lowest possible raw score range and possible score range were pre-specified and 
available in literature (171). The transformed sub-scales consisted of score range from 0 – 
100 for the 8 scales.  
Conversion of sub-scales into component summary scores 
After obtaining scores for the 8 sub-scales, we converted sub-scales’ scores into physical 
and mental component summary scores (PCS and MCS). The conversion of SF-36 sub-
scales into summary scores was based on work by Ware et al. (172, 173).  Physical 
functioning and emotional functioning are considered the purest measures for PCS and 
MCS respectively.  Body pain, general health, vitality and social functioning are 
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considered to be confounded sub-scales, as they contribute to a large extent to both PCS 
and MCS.   
The PCS and MCS summary scores were obtained by multiplying z-scores for each of the 
eight sub-scales by a factor score coefficient and the resulting scores were summed over 
the eight sub-scales by using formulas given in the manual by Ware et al. (175, p51).  
The PCS and MCS scores were translated into T-scores by multiplying the PCS and MCS 
scores by 10 and adding 50 to the product (118, p671).  We used previously written and 
verified Stata codes for PCS and MCS (177). 
 Both the primary outcome measures for our study i.e. PCS and MCS were continuous 
measures (0-100), with lower score indicating poor quality of life whereas higher score 
indicating better quality of life. 
Key Predictor Variable  
We measured perceived social support using Medical Outcome Studies Social Support 
(MOS SS) survey.  This measure of perceived social support which was constructed by 
Sherbourne and Stewart and captures four dimensions of perceived social support. These 
dimensions are derived from qualitative assessment of social ties and the degree to which 
these ties are linked to serve a particular function. The dimensions include 
emotional/informational support, tangible support, affectionate support and positive 
social interaction (30); the details of 19-items for the 4 dimensions are presented in Table 
4.   
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Table 4:  Dimensions of perceived social support using MOS SS (30) 
 
DIMENSIONS 
 
Emotional/                        
Informational                      
Support 
 
Tangible                                                                          
Support 
 
Affectionate
Support 
 
Positive        
Social                              
Interaction 
 
 
 
 
 
 
 
 
 
 
ITEMS 
 
Someone you can 
count on to listen to 
when you need to 
talk. 
Someone to confide 
in for your problems. 
Someone to turn for 
suggestions how to 
deal with problems  
Someone to give you 
information to help 
you understand a 
situation 
Someone to give you 
good advice about a 
crisis 
Someone whose 
advice you really 
want 
Someone to share 
your most private 
worries and fears 
with 
Someone who 
understands your 
problems 
 
 
Someone to 
help if 
confined to 
bed. 
Someone to 
help with 
daily chores. 
Someone to 
take you to 
the doctor if 
you needed 
it. 
Someone to 
prepare your 
meals if you 
were unable 
to do it 
yourself. 
 
 
Someone                   
who shows                       
love and 
affection. 
Someone to                       
hug you. 
Someone to                   
love you and                
make you                          
feel wanted. 
 
 
Someone to 
relax with you. 
Someone to 
have a good 
time with.
Someone to do 
something 
enjoyable with. 
 
 
 
  
Additional 
item  
  
Someone to do 
things with to 
help you get 
your mind off 
things 
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The measure was evaluated and found to be valid and reliable to assess perceived social 
support (30, 178). Sherbourne et al, concluded that the 19-item scale had high convergent 
and discriminant validity to determine perceived social support in four dimensions.  
The social support measure was also found to be empirically distinct from other measures 
of physical and mental health.  The authors found that the reliability of the item scales 
was also found to be stable over a period of one year.  Sherbourne and Stewart found that 
the MOS SS survey was easy to administer to chronically ill patients since the items were 
designed specifically to be short, simple and easy to understand and restricted to one idea 
in each stem (30).   
More recently Sherbourne et al., have used a 9-item scale to assess the four dimensions of 
perceived social support (178).  To date the 9-item scale for MOS SS survey has not been 
validated; however, in email correspondence, Sherbourne mentioned that she used the 9-
item version as a total scale for perceived social support and not tried using sub-scales. In 
her experience, the domains in the sub-scale could be highly correlated, for example an 
individual having tangible support may have other forms of support as well.   The alpha 
for this shorter version was 0.93 when used in a sample of the depressed population.  
Based on a similar discussion with Sherbourne, the investigators of the original study 
decided to use the 9 item scale for the patient surveys. 
Please refer to Appendix E for the 9-item MOS SS survey. Each item in the survey had 5 
corresponding answer categories and they were transformed into a 0 -100 scale for each 
item using a standard approach recommended by the RAND Corporation (179).  
 
  
 70     
 
To determine sores for each item and a total score for perceived availability of social 
support using the RAND scoring system, the following steps were used (179):  
1. Average score of each item was obtained. 
2. Minimum and maximum scores in each category were 1 and 5 respectively 
3. Each item was transformed to a  scale of 0-100 by using the following formula: 
{(average score – minimum possible score) / (maximum possible score- minimum 
possible score)}  × 100    
4. After each item score was transformed to a scale of 0-100, average of all 9 item 
scores was calculated. This average score was the score for ‘perceived social 
support.’ 
The perceived social support was thus transformed into a continuous scale (0-100) and 
was used as the key predictor variable in our study.  Lower scores showed lower 
perception of social support and higher scores demonstrated higher perception of 
available social support (30). 
Other variables associated with HRQOL 
Our conceptual framework shows that several variables could be associated with HRQOL 
in low SES women diagnosed with breast cancer. Nineteen of these variables were 
collected through the surveys conducted as part of the original study and analysed in our 
study. We categorized these variables into individual and systems-related variables to use 
in univariate, bivariate and multiple regression analyses in our study. All the variables 
were collected at 18 months after breast cancer diagnosis; except for age, ethnicity and 
education which were collected at 6 months after breast cancer diagnosis. Description of 
type as well as rationale behind coding of variables is given below. 
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Individual-related variables: 
Individual-related variables were further categorized into demographic factors, treatment 
related factors and psycho-social factors.   
Among the demographic factors, age was a continuous variable measured in years at the 
time of original diagnosis with breast cancer.  Ethnicity was collapsed into three 
categories, White, Latina and other races.  In the original study, there were 4 additional 
categories for ethnicity including African Americans, Asian Americans, Pacific Islanders, 
Native/Alaskan American. The number of respondents in the four additional categories 
for ethnicity was very low so we merged those four categories with the other races 
category in our study. 
Average family income was also grouped into two categories; families with average 
annual income of equal to or less than 20,000 USD and families with average family 
income of more than 20,000 USD annually. This categorization was based on the 
threshold of being below poverty line, which for a family of 4 in the US was almost 
20,000 USD in 2005 (70).  
High school education was determined as threshold to categorize women’s education 
level. Women were categorized into two categories of women: the first category 
consisted of women who had education below or up to high school level. The second 
category was of women who had completed some college or university degree.  The 
women were categorized as either post-menopausal or were still pre-menopausal at the 
time of diagnosis with breast cancer.   
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Treatment related factors included stage of disease, type of surgery, received 
chemotherapy, received radiation therapy, number of co-morbidities and treatment side-
effects.  The staging of breast cancer was based on TNM (Tumor Nodes Metastasis) 
staging as recommended by National Cancer Institute in the US (180). Three categories 
were used: Stage 0 or 1, Stage II (included large number of respondents) and Stage III or 
IV.   
Women in our study underwent two types of surgeries, mastectomy and breast-
conserving surgery.  The categorization of type of surgery was thus, mastectomy only, 
breast conserving surgery only and breast conserving surgery followed by mastectomy.  
Yes or no answers for those who received chemotherapy and radiation therapy were 
recorded.  
 A number of co-morbidities were listed in the original study.  The co-morbidities 
included having history of high blood pressure, peripheral vascular disease, stroke, 
cerebrovascular accident, transient ischemic attack, asthma, bronchitis, chronic 
obstructive lung disease, stomach ulcer, peptic ulcer, diabetes, lupus, polymyalgia 
rheumatica, Alzheimer’s, cirrhosis, leukemia, lymphoma, AIDS and cancer other than 
breast cancer.  In our study we added up the number of co-morbidities that each patient 
had.  Most patients did not have more than two co-morbidities, we categorized co-
morbidities into three groups; none, one or two and more than two.  
Possible treatment side effects were listed in the original study and included hot flashes 
nausea, vomiting, difficulty with bladder control, vaginal dryness, pain with intercourse, 
general aches and pains, joint pains, muscle stiffness, weight gain, unhappy with body 
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image, forgetfulness, night sweats, difficulty in concentration, arm swelling, decreased 
range of motion of the arm.  We categorized this variable into women who had less than 
or equal to 5 side effects of treatment and women who reported more than 5 side effects 
of breast cancer treatment.  
Anxiety, depression and marital status were the three psycho-social factors included in 
our study. Anxiety was coded as yes or no response to the current (18 months after breast 
cancer diagnosis) subjective feelings of anxiety, fear or anger.  Depression was coded as 
yes or no to the current feelings of depression, sadness or sense of loss.  Marital status 
was categorized as married/having a partner and not married/not having a partner. 
Systems-related variables: 
Systems-related variables were further categorized into health systems related factors and 
socio-ecological factors. 
Health systems related factors included regular access to health care, patient-doctor and 
patient-staff relationships.  Women were asked if they had regular access to health care 
i.e. for treatment other than cancer care, their yes/no responses were recorded and used in 
our study.   
To assess the patient-doctor/staff relationship, we assessed patient satisfaction with their 
clinicians.  In the original study, patients were asked to rate satisfaction with their 
surgeon, oncologist and radiation oncologist on a likert scale which had 5 options ranging 
from extremely satisfied to dissatisfied.  The majority of the respondents were extremely 
satisfied with their surgeon, oncologist and radiation oncologist; therefore, in our study 
we recoded the responses into extremely satisfied and not extremely satisfied.   
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Socio-ecological factors, according to our conceptual framework, included life burdens 
and neighbourhood resources.  We were only able to ascertain life burdens in the form of 
competing life needs.  Yes or no responses were recorded to the question that whether in 
the past year, the patient ever had to go without needed medical care because they had to 
spend money for food, clothing, housing or transportation. 
Missing data 
The outcome variables PCS and MCS each had 67 (10.5%) missing cases. There were no 
missing cases for the key predictor variable.  
Age, ethnicity, income, education, menopause status, type of surgery, treatment with 
surgery and radiation, comorbidity, anxiety, depression, marital status, current access to 
health care, satisfaction with surgeon and oncologist and competing life needs were 
variables with less than 5% missing data. 
A separate category of “missing” was created for those categorical variables which had 
more than 10% of data missing. Categorical variables with missing as an additional 
category included stage of disease, received chemotherapy and treatment side effects  
Data Analysis 
All analyses were performed using STATA Version 10 (181).  The unit of analysis was a 
woman who was a breast cancer survivor. 
Univariate analyses were performed on HRQOL summary scales (PCS and MCS), 
perceived social support and 19 other variables identified in the previous section.  Means 
and confidence intervals were measured for continuous variables which included: 
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outcome variables (PCS and MCS), key predictor variable (perceived social support) and 
age at the time of diagnosis.  Frequency and percentages were calculated for categorical 
variables which included all individual (except for age at the time of diagnosis) and 
systems-related variables.  
Bivariate analyses were used to look at the relationship of outcome variables (PCS and 
MCS) with predictor variables.  Simple linear regression was used to analyze relationship 
between outcome variables with key predictor variable and age. Comparisons of means 
and 95% confidence intervals were used to analyze the relationship between primary 
outcome variables and individual and systems-related variables.  
Primary outcome variables (PCS and MCS) were included in multiple regression analyses 
with key predictor variable and individual as well as systems-related variables.  Forward 
selection (entry criteria p<0.2) and backward elimination (exit criteria p <0.2) stepwise 
linear regression analyses were used to check for robustness of our main models.   
Regression Diagnostics 
Regression diagnostics were performed to fit the multiple regression models. Normality 
of residuals was tested using kernel density plots and normal probability plots. Residual 
versus fitted plots, imtest and hettest were used to assess homogeneity of the residuals.  
Variance inflation factors (VIF) was used to test for multicollinearity.  Model 
specifications were checked using the Omitted Variables test (ovtest). 
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  Chapter 4 
Results 
Sample population 
Six hundred and thirty four women diagnosed with breast cancer had completed all three 
surveys and were therefore included in our study. The mean scores for PCS and MCS 
were 43.2 and 46.9 respectively. The distribution of PCS and MCS scores is presented in 
Fig 6.   
Mean score for perceived social support among women in our study was 66.2.  The 
average age of women was 51 years at the time of their diagnosis with breast cancer.  A 
majority of women were Latina (55.0%) followed by White (28.0%).  Other races made 
up 17% of the sample population and included: African American, Asian Americans, 
Pacific islanders, American Indians, Alaskan natives and women who did not specify 
their ethnicity. 
Every woman was receiving medical care through the Medi-Cal’s BCCPT program and 
their income was < 200% of the Federal Poverty Level; a majority of women had family 
income of ≤ 20,000 US dollars (64.1%) annually and most of them (59.4%) had 
education up to or less than high school.  Fifty percent women were post-menopausal at 
the time of their diagnosis with breast cancer. Most women (46.0%) were diagnosed with 
stage II breast cancer, less than 13% had more severe or metastatic disease at the time of 
their diagnosis. Twenty two percent women were diagnosed with stage 0 or I of the breast 
cancer. Distribution of variables in our sample population is given in Table 5. 
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Fig 6: Distribution of PCS and MCS scores. 
 (Comparison of means standard deviations and range for PCS and MCS scores) 
 
 
Abbreviations:                                                                                                                                     
SD = Standard deviation                                            
Max = Maximum score                           
Min = Minimum score                                                                        
PCS = Physical Component Summary scores                                           
MCS = Mental Component Summary scores 
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Table 5:  Distribution of variables in our sample population; univariate analyses results 
Variables Total number of cases N = 634 
  
Outcome variables  Mean (95% Confidence Interval) 
Physical component summary scores 
(PCS) a 
43.2 (42.3 to 44.1) 
Mental component summary  scores 
(MCS) a 
46.9 (45.9 to 47.9) 
Key predictor variable    
Perceived social support 66.2 (64.2 to 68.2) 
Individual-related variables  
Demographic factors  
Age 50.8 (50.1 to 51.2) 
 Number of cases (%) 
Ethnicity   
     Latina 349 (55.0%) 
     White 178 (28.1%) 
     Other races 107 (16.9 %) 
Income  (US dollars) b  
     ≤ 20,000 404 (64.1%) 
     > 20,000 226 (35.9%) 
Education   
     ≤ High School 377 (59.5%) 
      > High School 257 (40.5%) 
Menopause  
     Premenopausal 313 (49.4 %) 
     Postmenopausal 321 (50.6 %) 
a. Continuous variables with 67 (10.5%) missing cases; measured in units.   b. Categorical variable with 4 (0.6%) missing cases; 
measured in 2005 US dollars.                                                                                    Continued on the next page…  
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                                                          Continued on the next page…       
Treatment related factors  
Stage of breast cancer  
     0 –I  140 (22.1%) 
     II  292 (46.1%) 
     III- IV 81 (12.7 %) 
     Missing 121 (19.1%) 
Type of surgery  
     Mastectomy only 212 (33.4%) 
     Breast conserving surgery only 329 (52.0%) 
     Breast conserving surgery followed by    
mastectomy 
93 (14.7%) 
Received chemotherapy  
     No 190 (30.0%) 
     Yes 444 (70.0%) 
Received radiation therapy   
     No 179 (28.2%) 
    Yes 455 (71.8%) 
Number of co-morbidities   
     None 366 (57.7%) 
     One 179 (28.2%) 
     ≥ 2 89 (14.1%) 
Treatment side effects   
     ≤ 5 226 (35.6%) 
     > 5 231 (36.4%) 
    Did not report any side effects 177 (28.0%) 
Psycho-social factors  
Anxiety  
     No 179 (28.2%) 
    Yes 455 (71.8%) 
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Depression  
     No 332 (52.4%) 
     Yes 302 (47.6%) 
Marital status  
     Married/ having a partner 320 (50.5%) 
     Not married/ Not having partners 314 (49.5%) 
Systems-related variables   
Health systems related factors   
Currently access to health care other than cancer care   
     No 164 (25.9%) 
     Yes 470 (74.1%) 
Satisfaction with treatment by surgeon a   
     Extremely satisfied 464 (74.4%) 
     Not extremely satisfied 160 (25.6%) 
Satisfaction with treatment by oncologist b  
     Extremely satisfied 423 (71.9%) 
     Not extremely satisfied 165 (28.1%) 
Satisfaction with treatment by radiation oncologist c  
     Extremely satisfied 376 (59.3%) 
     Not extremely satisfied 82 (12.9%) 
Socio-ecological factors   
Competing life needs d   
     No 51 (81.1%) 
     Yes 581 (91.9%) 
a. Categorical variable with 10 (1.5%) missing cases.                                                                                                                      
b. Categorical variable with 46 (7.2%) missing cases.                                                                                                          
c. Categorical variable, 179 (28.2%) did not receive radiation therapy; however, 3 of these 179 responded to the satisfaction 
with treatment by radiation oncologist.                                                                                                                                                          
d. Categorical variable with 2 (0.003%) missing cases. 
Note:  The scores for outcome variables ranged from 0 to 100, 0 = worst HRQOL and 100 = best HRQOL.   The scores 
for perceived social support ranged from 0 to 100, 0 = no support and 100 = maximum    support                                                    
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Our results showed that 52%women required only breast conserving surgery, mastectomy 
was performed in 33% women and 15% had breast conserving surgery followed by 
mastectomy. Seventy percent women received chemotherapy and almost 72% received 
radiation therapy. 
According to our results 28% women had one co-morbidity and 14% had ≥ 2 co-
morbidities while 57% had no co-morbidities at the time of their diagnosis with breast 
cancer.  Thirty five percent women had ≤ 5 and 36% had > 5 treatment side effects. 
Twenty eight percent women did not report any treatment side effects. 
Feelings of anxiety after 18 months of diagnosis with breast cancer were present in 71% 
women, less than 48% reported having feelings of depression at the same time. Half of 
the women (50.5%) were married or living with a partner. 
One hundred and sixty four (24.4%) women did not have access to health care other than 
cancer care.  More than 70% women were extremely satisfied with their surgeon and 
oncologist while less than 60% were extremely satisfied with their radiation oncologist 
(Table 5). 
Our results showed that 91% women had competing life needs 18 months after diagnosis 
with breast cancer i.e. they had to go without medical care in the past year because they 
had to spend money for food, clothing, housing or transportation. 
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Bivariate analyses results 
The results for bivariate analyses of physical component summary scores (PCS) and 
mental component summary scores (MCS) with predictor variables are presented in 
Table 6 and Table 7 respectively. 
Physical component summary scores (PCS): 
Table 6 shows associations between PCS and predictor variables. The association 
between PCS and perceived social support was found to be statistically significant (p < 
0.01) on bivariate analysis.  
Those who received chemotherapy or radiation therapy had lower PCS scores (42.0 and 
42.7, respectively) as compared to women who did not receive chemotherapy or radiation 
therapy (46.2 and 44.4, respectively).  The difference was significant for women 
receiving chemotherapy but, not significant for women receiving radiation therapy.   
Mean PCS scores for women who had one comorbidity (41.8) or two or more 
comorbidities (38.3) were significantly lower than women who had no comorbidities 
(95% CI = 43.9 to 46.1).  Women reporting > 5 treatment side effects had lower mean 
PCS scores (41.0) as compared to those who reported ≤ 5 treatment side effects (95% CI 
= 45.2 to 48.1) (Table 6). 
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Table 6: Relationship between PCS scores and predictor variables; bivariate analyses 
results. 
Predictor variables Outcome variable 
Physical component summary score 
 N = 567 
 R a  (95% Confidence Interval) 
  
Key predictor variable  
Perceived social support 0.06 (0.03 to 0.09)* 
Individual-related variables  
Demographic factors  
Age 0.04 (-0.05  to 0.1) 
 Mean (95% Confidence Interval) 
Ethnicity  
     Latina  42.8  (41.6 to 44.0) 
     White 43.4   (41.8 to 45.1) 
     Other races 44.1   (41.9 to 46.3)  
Income  (US dollars)  
     ≤ 20,000  43.3   (42.1 to 44.4) 
     > 20,000 43.0  (41.6 to 44.4) 
Education  
     ≤ High School  42.9 (41.8 to 44.1) 
      > High School 43.6 (42.2 to 44.9) 
Menopause   
     Premenopausal  44.4  (43.4 to 44.4) 
     Postmenopausal  42.0  (40.7 to 43.4)  
                                                 
                                                                 Continued on the next page… 
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Predictor variables Mean (95% Confidence Interval) 
Treatment related factors  
Stage of breast cancer  
     0 –I  43.4 (41.4 to 45.4) 
     II  43.1 (41.8 to 44.3) 
     III- IV 41.0 (38.5 to 43.5)  
     Missing 44.9 (43.1 to 46.8) 
Type of surgery  
     Mastectomy only  42.8 (41.3 to 44.4) 
     Breast conserving surgery only 43.0 (41.7 to 44.3) 
     Breast conserving surgery followed by 
mastectomy  
 44.7 (42.7 to 46.9)  
Received chemotherapy   
     No  46.2 (44.7 to 47.8) 
     Yes     42.0 (40.9 to 43.0) * 
Received radiation therapy   
     No  44.4 (42.8 to 46.1) 
    Yes  42.7 (41.7 to 43.8)  
Number of co-morbidities    
     None  45.0 (43.9 to 46.1) 
     One     41.8 (40.1 to 43.4) * 
     ≥ 2     38.3 (35.7 to 40.9) * 
Treatment side effects    
     ≤ 5  46.7 (45.2 to 48.1) 
     > 5     41.0 (39.7 to 42.4) * 
Did not report any side effects     41.5 (39.6 to 43.2) * 
Psycho-social factors  
Anxiety   
     No  44.5 (43.9 to 47.0) 
    Yes    42.3 (41.3 to 43.4) * 
                                                    Continued on the next page… 
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Predictor variables Mean (95% Confidence 
Interval) 
Depression   
     No  45.9 (44.9 to 47.1) 
     Yes    40.3 (38.9 to 41.6) * 
Marital status  
     Married/ having a partner  44.1 (42.9 to 45.3) 
     Not married/ Not having partners 42.4 (41.1 to 43.7) 
Systems-related variables   
Health systems related factors   
Current access to health care other than cancer 
care 
  
     No  43.1 (41.4 to 44.9) 
     Yes 43.3 (42.3 to 44.3) 
Satisfaction with treatment by surgeon    
     Extremely satisfied  43.6 (42.6 to 44.7) 
     Not extremely satisfied 42.1 (40.3 to 43.9) 
Satisfaction with treatment by oncologist   
     Extremely satisfied  43.6 (42.5 to 44.6) 
     Not extremely satisfied 41.5 (39.7 to 43.4) 
Satisfaction with treatment by radiation oncologist  
     Extremely satisfied  43.1 (41.9 to 44.2) 
     Not extremely satisfied  40.5 (37.9 to 42.9)  
Socio-ecological factors   
Competing life needs   
     No  40.4 (36.9 to 43.8) 
     Yes 43.5 (42.6 to 44.4) 
a. R: regression co-efficient                                                                    
* Mean PCS is significantly different from the reference category (p is significant at ≤ 0.05 % level) 
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Women having feelings of anxiety at 18 months after breast cancer diagnosis had 
significantly lower PCS scores (95% CI = 41.3 to 43.4) as compared to those who did not 
report having feelings of anxiety (95% CI = 43.9 to 47.0).  Women who reported having 
feelings of depression at 18 months after breast cancer diagnosis had significantly lower 
PCS scores (95% CI = 38.9 to 41.6) as compared to those who did not report having 
feelings of depression (95% CI = 44.9 to 47.1).   
We did not find statistically significant difference in PCS scores among any of the 
systems-related variables.  Although women who were not extremely satisfied with their 
surgeon, oncologist or radiation oncologist had lower mean PCS scores (42.1, 41.4 and 
40.5, respectively) as compared to women who were extremely satisfied with their 
surgeon, oncologist or radiation oncologist (43.1, 43.6 and 43.6, respectively) and these 
relationships were not statistically significant (Table 6). 
Mental component summary scores (MCS): 
Table 7 shows associations between MCS and predictor variables. The results showed 
statistically significant association between MCS and perceived social support (p < 0.01) 
on bivariate analysis.  
We did not find statistically significant differences in mean scores for MCS among the 
demographic factors (Table 7). 
Women having > 5 treatment side effects had significantly lower MCS scores (95% CI = 
42.4 to 45.8) as compared to those who reported ≤ 5 treatment side effects (95% CI = 
48.7 to 51.4). 
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Table 7: Relationship between MCS scores and predictor variables; bivariate analyses 
results  
Predictor variables Outcome variable 
Mental component summary score 
 N = 567 
 R a  (95% Confidence Interval) 
  
Key predictor variable  
Perceived social support 0.09 (0.05 to 0.1) * 
Individual-related variables  
Demographic factors  
Age 0.02 (-0.08 to 0.1) 
 Mean (95% Confidence Interval) 
Ethnicity  
     Latina  47.0 (45.7 to 48.3) 
     White 46.6 (44.4 to 48.2) 
     Other races 47.2 (44.6 to 49.7) 
Income  (US dollars)  
     ≤ 20,000  47.0 (45.7 to 48.2) 
     > 20,000 46.4 (44.8 to 48.1) 
Education  
     ≤ High School  46.7 (45.5 to 48.0) 
      > High School 47.0 (45.5 to 48.6) 
Menopause  
     Premenopausal  46.5 (45.1 to 48.0) 
     Postmenopausal 47.2 (45.8 to 48.5) 
                                                             Continued on the next page… 
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Predictor variables Mean (95% Confidence 
Interval) 
Treatment related factors  
Stage of breast cancer  
     0 –I  47.7 (45.5 to 49.9) 
     II  46.6 (45.1 to 48.1) 
     III- IV 44.8 (41.8 to 47.9)  
     Missing 47.9 (45.8 to 49.9) 
Type of surgery  
     Mastectomy only  47.3 (45.6 to 49.1) 
     Breast conserving surgery only 46.9 (45.6 to 48.3) 
     Mastectomy and breast conserving surgery  45.4 (42.8 to 48.0)  
Received chemotherapy  
     No  48.0 (46.3 to 49.8) 
     Yes 46.4 (45.2 to 47.6) 
Received radiation therapy   
     No  47.4 (45.5 to 49.3) 
    Yes 46.7 (45.5 to 47.8) 
Number of co-morbidities   
     None  47.5 (46.3 to 48.7) 
     One 46.4 (44.4 to 48.4) 
     ≥ 2  45.0 (42.1 to 47.9)  
Treatment side effects    
     ≤ 5  50.0 (48.7 to 51.4) 
     > 5    44.1 (42.4 to 45.8) * 
Did not report any side effects    46.4 (44.3 to 48.7)  
Psycho-social factors  
Anxiety   
     No  52.3 (50.8 to 53.7) 
    Yes   44.7 (43.4 to 45.9) * 
                                                Continued on the next page… 
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Predictor variables Mean (95% Confidence 
Interval) 
Depression   
     No  51.1 (49.9 to 52.3) 
     Yes    42.2 (40.8 to 43.7) * 
Marital status  
     Married/ having a partner  46.9 (45.6 to 48.3) 
     Not married/ Not having partners 46.8 (45.3 to 48.2) 
Systems-related variables   
Health systems related factors   
Current access to health care other than cancer 
care 
  
     No  46.5 (44.5 to 48.5) 
     Yes 46.9 (45.8 to 48.1) 
Satisfaction with treatment by surgeon    
     Extremely satisfied  46.9 (45.8 to 48.1) 
     Not extremely satisfied  46.7 (44.0 to 48.6) 
Satisfaction with treatment by oncologist   
     Extremely satisfied  47.2 (46.0 to 48.4) 
     Not extremely satisfied  45.6 (43.5 to 47.7)  
Satisfaction with treatment by radiation oncologist  
     Extremely satisfied 46.9 (45.6 to 48.1) 
     Not extremely satisfied 44.9 (42.1 to 47.8)  
     Did not receive radiation therapy 47.6 (45.8 to 49.5) 
Socio-ecological factors   
Competing life needs    
     No  38.2 (34.2 to 42.3) 
     Yes   47.1 (46.1 to 48.1)* 
a. R: regression co-efficient                                                                    
* Mean MCS is significantly different from the reference category (p is significant at ≤ 0.05 % level) 
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Women having feelings of anxiety at 18 months after breast cancer diagnosis had 
significantly lower MCS scores (95% CI = 43.4 to 45.9) as compared to those who did 
not report having feelings of anxiety (95% CI = 50.8 to 53.7).  Women who reported 
having feelings of depression at 18 months after breast cancer diagnosis had significantly 
lower MCS scores (95% CI = 40.8 to 43.7) as compared to those who did not report 
having feelings of depression (95% CI = 49.9 to 52.3).    
Among systems-related variables, women who had competing life needs i.e. they had to 
go without medical care in the past year because they had to spend money for food, 
clothing, housing or transportation statistically, had significant higher MCS scores (95% 
CI = 46.1 to 48.1) as compared to those who did not have competing life needs (95% CI 
= 39.9 to 47.8).   
Women who were not extremely satisfied with their oncologist or radiation oncologist 
reported lower mean MCS scores (45.6, and 44.9, respectively) as compared to women 
who were extremely satisfied with their oncologist or radiation oncologist, the 
associations were not statistically significant (Table 7).   
Multiple regression analyses results  
The results of multiple regression analyses for the variables associated with the two 
primary outcome variables PCS and MCS are presented in Table 8 and Table 9 
respectively. The results were confirmed by forward selection stepwise regression models 
for PCS and MCS presented in Appendix F and Appendix H respectively and backward 
elimination stepwise regression models for PCS and MCS presented in Appendix G and 
Appendix I respectively.  
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Physical component summary scores (PCS) 
Table 8 describes variables associated with physical component summary scores (PCS) 
from multiple regression. The model was statistically significant (p <0.01).  Twenty three 
percent of the variability in the model was accounted for by the variables in the model.  
Perceived social support was not significantly associated with PCS scores (p = 0.4) on 
multiple regression analysis. 
Among other factors associated with PCS scores, women who were post-menopause at 
the time of diagnosis with breast cancer had worse PCS scores than women who were 
pre-menopausal at the time of their diagnosis (β = -2.3, p = 0.01) (Table 8). 
Women receiving chemotherapy had significantly lower PCS scores (β = -4.5, p < 0.01) 
compared to women who did not receive chemotherapy, whereas; women who received 
radiation therapy had better PCS scores β = 4.4, p = 0.04) than those who did not receive 
any radiation therapy. 
Women with one co-morbidity had significantly lower PCS scores (β = -2.6, p = 0.01), 
those who had 2 or more co-morbidities also had even lower PCS scores (β = -6.0, p < 
0.01) PCS scores when compared with women who did not have any co-morbidity.  Our 
results also showed that women reporting > 5 treatment side effects had significantly 
lower PCS scores when compared to those who reported ≤5 treatment side effects (β = -
3.6, p < 0.01). 
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Table 8: Multiple regression analysis results for PCS scores 
Predictor variables Outcome variable 
Physical component summary score 
 N = 515 
β a  (95% Confidence Interval) p-value 
   
Key predictor variable   
Perceived social support 0.01 (-0.2 to 0.05) 0.4 
Individual-related variables   
Demographic factors   
Age 0.04 (-0.04 to 0.1) 0.3 
   
Ethnicity   
     Latina  Reference category  
     White 1.3 (-0.9 to 3.6) 0.2 
     Other races 1.8 (-0.7 to 4.4 0.2 
Income  (US dollars)   
     ≤ 20,000  Reference category  
     > 20,000 -0.7 (-2.5 to 1.0) 0.4 
Education   
     < High School  Reference category  
      ≥ High School -0.6 (-2.6 to 1.4) 0.5 
Menopause    
     Premenopausal  Reference category  
     Postmenopausal -2.3 (-4.1 to -0.5) 0.01* 
                 
                                Continued on the next page… 
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 β a  (95% Confidence Interval) p-value 
Treatment related factors   
Stage of breast cancer    
     0 –I  Reference category  
     II   1.8 (-0.5 to 4.3)  0.1 
     III- IV -1.6 (-5.0 to 1.7) 0.3 
     Missing 1.1 (-1.9 to 4.1) 0.4 
Type of surgery    
     Mastectomy only  Reference category  
     Breast conserving surgery only -0.4 (-2.7 to 1.9) 0.7 
     Mastectomy and breast conserving surgery 1.7 (-0.9 to 4.3) 0.2 
Received chemotherapy    
     No  Reference category  
     Yes -4.2 (-6.7 to -1.8) 0.001* 
Received radiation therapy    
     No  Reference category  
    Yes 5.4 (0.2 to 10.6) 0.04* 
Number of co-morbidities     
     None  Reference category  
     One -2.6 (-4.7 to -0.5) 0.01* 
     ≥ 2 -6.3 (-9.0 to -3.7) 0.00* 
Treatment side effects     
     ≤ 5  Reference category  
     > 5 -3.7 (-5.7 to -1.6)  0.00* 
Did not report any side effects -2.1 (-4.5 to 0.3)  0.08 
Psycho-social factors   
Anxiety    
     No  Reference category  
    Yes -1.0 (-3.1 to 1.0) 0.3 
                                                                                                  
         Continued on the next page… 
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 β a  (95% Confidence Interval) p-value 
Depression    
     No  Reference category  
     Yes -4.1 (-6.0 to -2.1) 0.00* 
Marital status   
     Married/ having a partner Reference category  
     Not married/ Not having partners -0.6 (-2.5 to 1.3) 0.5 
Systems-related variables    
Health systems related factors    
Current access to health care other than cancer 
care 
   
     No  Reference category  
     Yes -0.09 (-1.9 to 2.1) 0.9 
Satisfaction with treatment by surgeon     
     Extremely satisfied  Reference category  
     Not extremely satisfied -1.0 (-3.1 to 1.0) 0.3 
Satisfaction with treatment by oncologist    
     Extremely satisfied  Reference category  
     Not extremely satisfied -1.0 (-3.0 to 1.1) 0.3 
Satisfaction with treatment by radiation oncologist   
     Extremely satisfied  Reference category  
     Not extremely satisfied  -2.3 (-5.0 to 0.3) 0.09 
     Did not receive radiation therapy   4.6 (-0.7 to 9.9) 0.09 
Socio-ecological factors    
Competing life needs    
     No  Reference category  
     Yes -0.5 (-3.3 to 3.2) 0.9 
*Significant at ≤ 0.05 % level                                                                                                                                                                                                                                            
a: regression co-efficient                                                                                                                                                                         
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Women who were feeling depressed after 18 months after diagnosis with breast cancer 
had lower PCS scores as compared to women who did not report feelings of depression (β 
= -4.1, p < 0.01).  We were not able to find statistically significant association between 
feelings of anxiety at 18 months after diagnosis with breast cancer and PCS scores. 
Mental component summary scores 
Table 9 describes variables associated with mental component summary scores (MCS) 
from multiple regression. The model was statistically significant (p < 0.01).  Twenty one 
percent of variability in the model was accounted for by the variables in the model.   
Perceived social support was not found to be significantly associated with MCS scores (p 
= 0.1) on multiple regression analysis.  
At the individual-related, demographic factors were not found to be significantly 
associated with MCS scores (Table 10).  Among treatment related factors, having 2 or 
more co-morbidities was associated with lower MCS scores (β = -2.5, p = 0.1).  Feelings 
of anxiety and depression at 18 months after breast cancer diagnosis were significantly 
associated with lower MCS scores (β = -4.2, p < 0.01 and β = -6.9, p < 0.01, 
respectively).  Systems-related variables were not significantly associated with MCS 
scores in our study (Table 9). 
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Table 9: Multiple regression analysis results for MCS scores 
Predictor variables Outcome variable 
Mental component summary scores 
 N = 515 
R a  (95% Confidence Interval) P-value 
   
Key predictor variable   
Perceived social support  0.03 (-0.007 to 0.07) 0.1 
Individual-related variables   
Demographic factors   
Age 0.05 (-0.05 to 0.1) 0.3 
   
Ethnicity   
     Latina  Reference category  
     White -1.8 (-4.4 to 0.7) 0.2 
     Other races -0.3 (-3.2 to 2.7) 0.8 
Income  (US dollars)   
     ≤ 20,000  Reference category  
     > 20,000 -0.3 (-2.3 to 1.8) 0.8 
Education   
     < High School  Reference category  
      ≥ High School 1.3 (-0.9 to 3.6) 0.3 
Menopause    
     Premenopausal  Reference category  
     Postmenopausal 1.3 (-0.7 to 3.4) 0.2 
                  
Continued on the next page… 
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 β a  (95% Confidence Interval) p-value 
Treatment related factors   
Stage of breast cancer    
     0 –I  Reference category  
     II  0.04 (-2.7 to 2.8) 0.9 
     III- IV -1.5 (-5.4 to 2.3) 0.4 
     Missing 2.3 (-1.2 to 2.7) 0.2 
Type of surgery    
     Mastectomy only  Reference category  
     Breast conserving surgery only 0.6 (-2.1 to 3.3) 0.6 
     Mastectomy and breast conserving surgery -1.2 (-4.3 to 1.7) 0.4 
Received chemotherapy    
     No  Reference category  
     Yes 0.5 (-2.2 to 3.3) 0.7 
Received radiation therapy   
     No  Reference category  
    Yes 3.3 (-2.8 to 9.1) 0.3 
Number of co-morbidities    
     None  Reference category  
     One -0.7 (-3.0 to 1.6) 0.5 
     ≥ 2 -2.5 (-5.5 to 0.4)    0.1 
Treatment side effects   
     ≤ 5  Reference category  
     > 5 -3.1 (-5.5 to -0.7)     0.009* 
Did not report any side effects -1.0 (-3.8 to 1.7)  0.4 
Psycho-social factors   
Anxiety    
     No  Reference category  
    Yes -4.2 (-6.6 to -1.9)     0.00* 
                                                                                            
Continued on the next page… 
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 β a  (95% Confidence Interval) p-value 
Depression   
     No  Reference category  
     Yes -6.7 (-8.9 to -4.5) 0.00* 
Marital status   
     Married/ having a partner Reference category  
     Not married/ Not having partners 0.6 (-1.5 to 2.8) 0.6 
Systems-related variables    
Health systems related factors    
Current access to health care other than 
cancer care 
   
     No  Reference category  
     Yes -0.5 (-2.8 to 1.8) 0.7 
Satisfaction with treatment by surgeon     
     Extremely satisfied  Reference category  
     Not extremely satisfied 1.2 (-1.2 to 3.5) 0.3 
Satisfaction with treatment by oncologist    
     Extremely satisfied  Reference category  
     Not extremely satisfied 0.5 (-2.9 to 1.8) 0.6 
Satisfaction with treatment by radiation 
oncologist  
  
     Extremely satisfied  Reference category  
     Not extremely satisfied -1.6 (-4.7 to 1.4) 0.3 
     Did not receive radiation therapy 4.5 (-1.5 to 10.6) 0.2 
Socio-ecological factors    
Competing life needs    
     No  Reference category  
     Yes -1.2 (-4.9 to 2.5) 0.5 
 * Significant at ≤0.05% level                                                        
a: regression co-efficient                                                                                                                                                                            
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Regression Diagnostics 
Kernel density plots and normal probability plots for both PCS and MCS multiple 
regression models showed normal distributions of the residuals in both models. Residual 
versus fitted plots, imtest and hettest indicated that variance of residuals in PCS and MCS 
multiple regression models was homogenous.  
We found mean variance inflation factor (VIF) of 1.9 for the PCS and mean VIF of 1.8 
for MCS; indicating that multicollinearity was not observed in our multiple regression 
models. The omitted variable test (ovtest) was not significant for both models (p = 0.2 for 
PCS and p = 0.07 for MCS); thus, that the multiple regression models did not have 
specification errors. 
Kernel density plots, normal probability plots and residual versus fitted plots for PCS are 
presented in Appendix J and for MCS are presented in Appendix K. 
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Chapter 5 
Discussion 
Sample population 
Our sample population consisted of women diagnosed with breast cancer. The majority 
(55%) of women was Latina. Percentage of Latinas in our sample was closer to the 
general population in California (37.5% Latinas) but different from the US (16% Latinas) 
and Canadian (0.7%) general populations (196, 197).   
Sixty four percent of women were living below the poverty threshold which was 20, 000 
US $ in 2005, around the time when the data were collected (198). This is very different 
from the general US population where 16.5% women were reported to be living below 
poverty threshold in 2010 (199). In Canada, almost 13% of the population (both male and 
female) were reported to be in low-income group in 2009 (200).  Although, the 
percentage of women below poverty threshold was very high, it is important to remember 
that our sampled population consisted of women belonging to lower SES.  
The incidence of breast cancer increases with increasing age.  More women were 
diagnosed between the ages of 49 and 69 (201).  The average age of women in our 
sample population was 51 years at the time of their diagnosis with breast cancer.  The 
number of women who had some college or university education was 40.5% which was 
lower than the percentage of college or university graduates in US (56.8%) and Canadian 
(50%) general populations (202, 203).  It is estimated that 16% of US population does not 
have access to health care (37).  Breast cancer care was available to all the women 
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through BCCPT coverage; but, a high percentage (26%) of women in our sampled 
population did not have access to health care other than cancer care. 
Univariate findings 
Understanding the factors associated with physical and mental HRQOL merits a 
discussion on interpretation of the variables used to depict HRQOL.  SF-36 physical and 
mental component summary scores (PCS and MCS) represent physical HRQOL and 
emotional HRQOL in variety of populations including breast cancer patients (67-70, 
182).   
To interpret the results of PCS and MCS scores, Ware et al. established norm based 
scoring for the physical and mental component summary scores.  The summary measures 
have a mean of 50 and standard deviation of 10 for general US population (67). The 
difference from norm based mean scores determines the physical and emotional HRQOL 
for a specific population. Lower scores depict poor HRQOL and higher scores suggest 
excellent HRQOL (67, 172-176, 182). 
Through general population surveys, Ware et al. also compared the norm based scores 
derived from US data with nine European countries including Denmark, France, 
Germany, Italy, the Netherlands, Norway, Spain, Sweden and United Kingdom (182).  
Substantial agreement was found between the standard and country specific scoring 
algorithms for the two summary scores in all 10 countries which included the nine 
European countries and the US.  The authors thus recommended that the interpretation of 
the summary scores based on norm based scoring is valid for international studies in 
general and the nine participating countries in particular (182). 
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Canadian normative data for SF-36 health survey comes from the Canadian Multicentre 
Osteoporosis Study (CaMos) (183).  The study consisted of surveys designed to provide 
estimates of osteoporosis and osteoporosis related fractures.  CaMos collected data from 
9423 Canadian men and women age 25 and above, living in communities in and around 9 
major Canadian cities (183).  Canadians scored higher on both PCS (mean = 50.5) and 
MCS (mean = 51.7) as compared to their US counterparts.  Scores for Canadian women 
were slightly lower than general Canadian population (PCS mean = 49.7, MCS mean = 
50.9).  The scores for Canadian women were comparable to the norm based scores 
presented by Ware et al. (67, 182,183). 
Studies show that patients with chronic illnesses have lower scores for HRQOL as 
compared to general populations (67, 184-186).  Physical HRQOL is generally more 
adversely affected in patients with chronic illness (184, 185). In some cases such as 
chronic kidney disease, prolonged exposure to disease can also result in lower mental 
HRQOL for chronically ill patients (186).   
Both physical and emotional HRQOL were below average among breast cancer survivors 
in our study as PCS and MCS were below norm based mean scores (67).  Physical 
HRQOL was poorer than emotional HRQOL. Lower PCS scores have been reported in 
other studies evaluating HRQOL in breast cancer patients (187 – 189).  A population 
survey of women in Wisconsin (N = 2,763) used SF-36 to evaluate HRQOL among 
women with breast cancer.  Comparisons were made between healthy women and breast 
cancer survivors (187).  The participants were contacted four times for follow-up in 2002.  
Breast cancer survivors scored lower on PCS scores than control population regardless of 
time since diagnosis, which in some cases was up to 13 years. The MCS scores were also 
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lower in breast cancer patients as compared to the controls; however, two years after 
diagnosis with breast cancer, the MCS scores were similar in both groups (187).  Ganz et 
al. studied HRQOL in breast cancer patients across various treatment groups; they 
concluded that at the end of primary treatment for breast cancer, women reported good 
emotional functioning but poor physical functioning (188).  In a previous study, Ganz et 
al. reported that 6 years post-diagnosis with breast cancer both physical and mental 
HRQOL improved in women; however, overall breast cancer survivors reported better 
mental HRQOL as compared to physical HRQOL (189). 
Perceived social support was our key variable of interest. During development of the 
scale, Sherbourne et al. concluded that mean scores for overall perceived social support in 
general US population for the 19-item social support scale was 70.1 ± 24 (30).  Studies 
showed that patients with chronic illness such as chronic kidney disease and heart disease 
reported higher scores for perceived social support (mean ranging from 76.0 to 85.0) 
(190, 191).  Among breast cancer patients, a study comparing the impact of cancer in 
non-hodgkins lymphoma and breast cancer patients concluded that perception of social 
support was higher (84 ± 16) in these cancer patients as compared to general population 
(192). We found that perception of perceived social support was lower than average 
among breast cancer patients in our study i.e. 66 ± 26.  The women reported lower scores 
despite the fact that most women in our study were Latinas and generally the Latin 
culture is associated with strong familial ties and social support provided by close and 
extended family and friends (193 – 195). Several factors could have resulted in lower 
perception of social support among women in our sampled population.  Stress caused by 
the diagnosis of breast cancer, lower SES status or the fact that majority of women were 
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living in the US illegally could be some reasons affecting the perception of social support 
in these women (120, 157). 
Regression findings 
Factors associated with physical HRQOL  
Breast cancer survivors in our study reported poor physical HRQOL and lower than 
average perception of social support. Studies have suggested that perceived social support 
has a positive correlation with physical HRQOL (141,149) in breast cancer survivors; we 
were not able to find an association between perceived social support and physical 
HRQOL.  
Unlike Sammarco (141) and Lim et al. (149) who measured perceived social support and 
HRQOL at the same point in time, our study looked at the impact of perceived social 
support on HRQOL after a period of one and a half years. We evaluated the impact of 
perceived social support measured at 18 months after breast cancer diagnosis on physical 
HRQOL measured at 3 years after breast cancer diagnosis.  Although our study did not 
show a correlation between perceived social support and physical HRQOL in low income 
women with breast cancer, a correlation measured at shorter interval such as 6 or 12 
months cannot be ruled out. Both Sammarco and Lim et al. had fewer numbers of 
participants (100 in both studies). In addition, Samarco studied the relationship between 
perceived social support and HRQOL among younger women (only women less than 50 
years of age were recruited for the study) which could have led to difference in 
perception of social support among Sammarco’s and our study population (141).   
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Lim et al compared the effects of perceived social support on HRQOL between Korean 
and Korean American women.  Socio- cultural differences among the two populations 
contributed to the differences in perception of social support among Korean and Korean 
American women.  Perceived social support had an indirect impact on physical HRQOL.  
It was proposed by Lim et al. that perceived social support improved the general well-
being of a breast cancer patient, thus, dampening the effects of medication and physical 
symptoms of disease, leading to improvement in physical HRQOL (149).  Although, Lim 
et al. showed that there was an indirect relationship between perceived social support and 
physical HRQOL, our study shows that there is no direct relationship between these two 
factors. 
Several individual-related factors in our study were associated with physical HRQOL. No 
relationship was found between systems-related factors and physical HRQOL in our 
study.   
Women who were post-menopausal at the time of their diagnosis with breast cancer had 
poorer physical HRQOL after 3 years of diagnosis with breast cancer as compared to 
women who were pre-menopausal at the time of their diagnosis.  This relationship was 
not significant on bivariate analysis, however, it was found to be significant on multiple 
regression analyses in our study.  There are several physical symptoms of menopause 
such a fatigue, pain, hot flashes.  These symptoms are responsible for poor physical 
HRQOL in most post-menopausal women (83-84). Some studies suggest that the effects 
of menopause on physical HRQOL in women diagnosed with breast cancer are not 
enhanced due to the cancer diagnosis (83 -84). On the other hand, there are studies 
similar to ours which suggest that there is a difference in physical HRQOL among pre-
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menopausal and post-menopausal women and that women who had reached menopause 
at the time of their diagnosis had worse physical HRQOL  (85-87). 
 Other demographic factors such as age, ethnicity, income level and education had no 
association with physical HRQOL. 
Side effects such as nausea, vomiting and fatigue due to adjunct chemotherapy in breast 
cancer patients are known to decrease physical HRQOL among these women (23, 204). 
Our results were consistent with the findings in the literature. Almost 70% women in our 
study received chemotherapy and had worse physical HRQOL as compared to those who 
did not receive adjunct chemotherapy.  
The most common side effect of radiation therapy in breast cancer is mild to moderate 
skin irritation. Other side effects could include arm pit discomfort, chest discomfort, 
fatigue and low blood counts (205). Radiation therapy in women with breast cancer is 
also known to adversely affect physical health (23).  These affects are mostly short term 
because the most common side effect is skin irritation which does not have long term 
physical implications (205). Interestingly we found that women who received radiation 
therapy had better physical HRQOL. There are studies which suggest that radiation 
therapy does not have long term deleterious effects on physical health on women with 
breast cancer (205, 206). Since, more than a year had elapsed between radiation therapy 
for women in our study and measurement of physical HRQOL, it could account for 
improvements in physical HRQOL in these women.  
Physical co-morbidities have a negative impact on physical HRQOL in women with 
breast cancer (23). Kurtz et al studied the effects of 13 co-morbidities in older breast 
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cancer women. According to Kurtz et al. increasing the number of co-morbidities 
adversely affected physical health (207). Ververs et al. studied the impact of co-
morbidities resulting from axillary lymph node dissection in women with breast cancer. 
Physical HRQOL was found to be impaired in women having multiple co-morbidities 
(217). Our study also showed that multiple co-morbidities have an adverse effect on long 
term physical HRQOL. 
In addition, having more treatment side effects also has a negative impact on physical 
HRQOL among low SES women with breast cancer. Studies also show that treatment 
side effects including those of surgery as well as chemo and radiation therapies result in 
short term as well as long term impairment of physical health in breast cancer patients 
(23, 209, 210).  
Studies suggest that depression is a significant predictor of long term physical HRQOL in 
breast cancer survivors (98, 213-215). Christie et al. showed that lower income single 
Hispanic women with breast cancer have a higher risk of developing depression and 
suffering from the subsequent physical and mental deterioration as a result of 
psychosocial stress (216).   
Among psycho-social factors, the feeling of depression was the only factor in our study 
which showed a long term negative impact on physical HRQOL in women with breast 
cancer. Ashing-Giwa et al. did not find depression to be a significant predictor for long 
term poor physical health especially among Latinas (210). In another qualitative 
assessment of factors associated with HRQOL in breast cancer survivors, Ashing-Giwa et 
al. found that psychological distress caused by fear of recurrence of breast cancer and 
 
  
 108     
 
burden of illness resulted in deterioration of physical HRQOL in breast cancer patients.  
The same study showed that among Latinas social support served as a comforting factor 
against psychological distress (212).  
Our results were similar to other studies such as a meta-analysis of effects of stress on 
women with breast cancer (98) and an evaluation of depression as predictor for fatigue 
and poor health in breast cancer survivors (211).  Both studies suggested that fatigue due 
to depression among breast cancer survivors results in poor physical HRQOL. 
Factors associated with emotional HRQOL  
Among the factors associated with Mental HRQOL, perceived social support is 
considered as an important predictor of emotional health in breast cancer survivors (140-
154). However, we were not able to find an association between perceived social support 
and long term emotional HRQOL. 
Several studies suggest that social support both received and perceived has both direct 
and indirect effect on emotional HRQOL in breast cancer survivors (140 -154). Studies 
looking at volunteer peer groups providing face to face or telephonic support concluded 
that among breast cancer patients, those interventions which lead to interaction among 
breast cancer survivors had a positive effect on emotional HRQOL (140, 154).  Other 
studies such Lim et al.’s analysis of effect of perceived social support on Korean and 
American-Korean women suggests that among the group of women living in Korea, 
sense of strong family ties and stronger perception of social support served as a barrier 
for emotional harm resulting in better emotional HRQOL  (149). Similarly higher 
perception of social support among Turkish women (148) and Latinas (152) due to strong 
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family ties attributed to socio-cultural norms among these populations served as barriers 
to psychological distress and improved emotional HRQOL.   
The only factors associated with mental HRQOL in our study were treatment side effects 
and psycho social factors. As discussed previously, treatment side effects including those 
of surgery as well as chemo and radiation therapies result in impairment of health in 
breast cancer patients (23, 209, 210).  Literature suggests that physical health is impaired 
health due to treatment side effects. However, in some cases such as mastectomy, women 
suffer from impaired body image thus, having a long term effect on mental health (23, 
209). Our study showed women who reported more treatment side effects had worse 
mental HRQOL. 
Women with breast cancer experience higher incidence of psychological distress such as 
anxiety and depression as compared to general population (219).  Studies suggest that 
stress such as anxiety and/or depression related to breast cancer diagnosis emotional well-
being of breast cancer survivors (98, 220). Our study also, shows that feelings of anxiety 
and depression experienced 18 months after the diagnosis of breast cancer have a long 
term adverse effect on mental HRQOL.  
Studies among Hispanic populations suggest that family support is an important stress 
alleviator in women with breast cancer especially among Latinas with low income (210, 
216).  In addition marital status is an important predictor for psycho-social stress in 
Latinas with breast cancer (216). A comparison between women newly diagnosed with 
breast cancer and those who had recurrence of the disease showed that being married was 
associated with better emotional well-being among women in both groups (221). The 
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study also showed that being single was a risk factor for long term depression in women 
with breast cancer.  On the other hand some studies suggest that marital distress due to 
diagnosis of breast cancer can cause stressful events leading to increase in depression 
among women diagnosed with breast cancer (92, 222). 
Our study did not report any association between systems-related variables and physical 
or emotional HRQOL. However, a study evaluating the effects of treatment and the 
process of care among older breast cancer survivors in the US found a positive 
relationship between these factors. The study concluded that satisfaction with the 
treatment process in addition to the therapy was a significant predictor of long term 
HRQOL in older breast cancer patients (218).  It is important to keep in mind that 
systems-related variables in our study consisted of access to health care in addition to 
satisfaction with treating clinicians and we did not evaluate the effects of treatment 
process on HRQOL. In addition, in contrast to the above mentioned study which was 
conducted among older women, our study included younger as well as older women with 
breast cancer. 
Limitations 
Although we were able to thoroughly analyse the relationship between perceived social 
support and HRQOL among low SES women with breast cancer, we had a few 
limitations to our study.  
Our study was limited by the dataset used for analysis. As a secondary dataset, it was 
originally designed to assess the determinants of breast cancer treatment in an 
underserved population.  The original data set was composed of factors associated with 
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determinants of breast cancer treatment and breast cancer care.  Evaluation of social 
determinants of breast cancer care was not the primary aim of the original study; 
therefore, the data did not contain some variables such as diet and exercise, estrogen and 
progesterone receptor status, uncertainty, repression/denial, expression and supportive 
care.  These variables are presented in our conceptual framework and could have 
provided us with further information about the relationship between perceived social 
support and HRQOL.  
Our sample population was unique.  Data were collected from women belonging to low 
SES in the state of California. Latinas were the ethnic majority with in the sampled 
population, whereas, they are a minority within general US population. It is important 
therefore, to cautiously interpret the results of our study. 
We used a sample consisting of women participating in all three surveys. In doing so, we 
may have missed some women who were unavailable to participate due to any number of 
reasons such lack of reliable address or being too sick to participate in the study. 
In addition, the results of our study may have been different if the time period between 
measurement of perceived social support and HRQOL was shorter such as 6 or 12 
months instead of 18 months. 
Implications of our study and future research 
Through our research we were able to explore the long term relationship between 
perceived social support and HRQOL in breast cancer survivors among women belonging 
to low SES. Factors influencing this relationship were also explored. Our research 
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therefore, yielded information which will be beneficial to individual breast cancer 
patients as well as public health policy makers. 
Our study identified multiple co-morbidities, menopause at the time of diagnosis with 
breast cancer, and adjunct chemotherapy as indicators for poorer long term physical 
HRQOL. Higher number of treatment side effects and depression in women with breast 
cancer resulted in poor physical and mental HRQOL. Anxiety in women with breast 
cancer was identified as an indicator for poorer mental HRQOL.  Information regarding 
factors associated with HRQOL provides useful information regarding the physical and 
mental well-being of breast cancer survivors. The knowledge acquired through this 
research can help in educating survivors about their risk of impaired physical and mental 
health during the course of their illness.  
The information gained through analysing factors affecting HRQOL is also useful for 
policy makers and informers of clinical practice guidelines. Resources can be allocated to 
earlier identification of modifiable factors such as treatment related side effects and 
development of stress related factors such as anxiety and depression, in order to offset the 
long term physical and mental impact on HRQOL. Similarly HRQOL in breast cancer 
survivors can be improved through introduction of clinical practice guidelines focusing 
on factors affecting HRQOL in breast cancers survivors.  
Results from this study can be useful in better informing the clinical practice guidelines 
for breast cancer care.  At present the guidelines suggest psychosocial counselling for 
women diagnosed with breast cancer without specific goals for such counselling. With 
the identification of vulnerable populations (such as anxious or depressed women), 
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clinical practice guidelines can be modified to incorporate additional surveillance options 
for women with breast cancer.  
Additionally, our research indicates a need for further exploration of the relationship 
between psychological factors and perceived social support.  Both anxiety and depression 
were strongly correlated with perceived social support in our study (β = -7.2, p = 0.02 and 
β = -13.8, p = <0.01, respectively). Anxiety and depression were also strongly associated 
with both physical and emotional HRQOL in our study. Perceived social support acts as a 
buffer against stressors of breast cancer. It is possible that strong negative correlations of 
anxiety and depression may have diluted the buffering effect of perceived social support 
in our population. Therefore, it is important to investigate the role of psychological 
factors such as anxiety and depression on the relationship between perceived social 
support and HRQOL in future studies. 
Our study was an exploratory analysis of the relationship between perceived social 
support and physical as well as emotional HRQOL in low SES women with breast 
cancer. We were able to identify some factors related to HRQOL. There is a need to 
further explore the nature of this relationship between perceived social support and 
HRQOL among low SES.  
In future, longitudinal studies evaluating the factors associated with perceived social 
support and their effect on HRQOL at regular time intervals will yield useful information 
for the patients as well as public health policy makers.  We were not able to explore the 
systems related factors in detail.  Future studies evaluating the impact of systems related 
factors on the relationship between perceived social support and HRQOL would provide 
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useful knowledge in understanding of this relationship.  In addition, we would propose 
the use of validated scales for anxiety and depression for future studies evaluating the 
relationship between perceived social support and HRQOL. 
Conclusions 
A statistically significant association between perceived social support and long term 
physical or emotional HRQOL in low SES women with breast cancer was not established 
through our study. However, several other factors affecting HRQOL in low SES women 
with breast cancer were identified. Multiple co-morbidities, menopause at the time of 
diagnosis with breast cancer, and adjunct chemotherapy are poor prognostic factor for 
long term physical HRQOL. Higher number of treatment side effects and depression in 
women with breast cancer results in poor physical and emotional HRQOL. Anxiety in 
women with breast cancer was identified as poor prognostic factor for emotional 
HRQOL. 
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Appendices 
Appendix A: Original study recruitment flow chart. 
 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
1869 Letter Mailed from BCCTP                                                          
(1st letters mailed 1-30-04, last mailed 5-28-05) 
 
160 refused 
544 agreed to further contact 
 
1165 did not return response 
form 
 
1709 attempted to contact 78 refused 
 
361 Ineligible                                                                
29 – deceased                                                               
183 – do not speak English or Spanish                                          
13 – misdiagnosed                                                                      
18 – diagnosed with previous cancer for > 
months               69- previous diagnosis of 
breast cancer                                  7 – 
currently treatment for cancer                                      
13 – not cognitively able to participate                            
29 – did not receive BCCTP benefits 
 
234 could not contact 
1036 eligible and agreed to 
participate 
 
921 completed baseline 
telephone survey 
 
115 did not complete 
baseline telephone 
survey  
 
Our study 
recruitment 
given in Fig 
3 
 
798 completed 18 
month telephone survey  
 
123 did not complete the 
18 month telephone survey 
 
666 completed the 36 
month telephone survey  
 
132 did not complete the 36 
month telephone survey 
 
634 completed all three 
telephone surveys 
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Appendix B: Time line of data collection and variables collected at those points 
 
 
 
                                          
 
                      
  
  
 
  
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T1: Baseline survey 6 months 
post breast cancer diagnosis  
March 2003 to August 2005 
 
T2:18 months post breast 
cancer diagnosis 
September 2004 to October 
2006 
 
T3: 36 months post breast 
cancer diagnosis 
May 2005 to July 2008 
 
Variables at 
Baseline survey  
 
1. Age 
2. Menopause 
3. Ethnicity 
4. Education 
 
 
Variables at 18 months 
survey 
 
1. Perceived availability of 
social support 
2. Income 
3. Marital Status 
4. Feeling of Anxiety 
5. Feeling of depression 
6. Access to health care 
other than cancer care 
7. Satisfaction with the 
surgeon 
8. Satisfaction with the 
oncologist 
9. Satisfaction with the 
radiation oncologist 
10. Competing life needs 
11. Access to health care 
other than cancer care 
 
Variables through Medical 
Chart Review at 18 months 
after breast cancer 
diagnosis 
 
1. Stage of disease 
2. Type of Surgery 
3. Surgery and 
Chemotherapy 
4. Surgery and 
Radiation therapy 
5. Number of co-
morbidities  
Variables at 36 
months survey 
 
HRQOL 
 
 
  
 140     
 
Appendix C:  Medical Outcome Study Short Form-36 (MOS SF-36) Survey 
 
i. General Health 
1. In general, would you say your health is?  
Excellent (1) Very Good (2) Good (3) Fair (4) Poor (5) 
How TRUE or FALSE is each of the following statements for you? 
 Definitely true (1) Mostly true (2)  Don’t know (3)  Mostly false (4)  Definitely false (5) 
2.  I seem to get sick a little easier than other people  
 3.  I am as healthy as anybody I know 
4.  I expect my health to get worse 
 
5.  My health is excellent 
ii. Physical Functioning 
The following items are about activities you might do during a typical day. Does your health now limit you in these 
activities? If so, how much?  
Yes, limited a lot (1) Yes, limited a little (2) Not limited at all (3) 
6.  Vigorous activities, such as running, lifting heavy objects, participating in strenuous sport 
7.  Moderate activities, such as moving a table, pushing a vacuum cleaner, bowling, or playing golf 
8.  Lifting or carrying groceries 
9.  Climbing several flights of stairs 
10.  Climbing one flight of stairs 
11.  Bending, kneeling, or stooping 
12.  Walking more than a mile 
13.  Walking several blocks 
14.  Walking one block 
15.  Bathing or dressing yourself 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii. Role – Physical 
During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as 
a result of your physical health? 
 Yes (1)  No (2) 
16.  Cut down on the amount of time you spent on work or other activities 
17.  Accomplished less than you would like 
18.  Were limited in the kind of work or other activities you did 
19.  Had difficulty performing the work or other activities (for example, it took extra time) 
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iv. Role - Emotional  
During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities as 
a result of any emotional problems (such as feeling depressed or anxious)? 
 Yes (1)  No (0) 
20.  Cut down on the amount of time you spent on work or other activities 
 
 
21.  Accomplished less than you would like 
22.  Didn’t do work or other activities as carefully as usual 
v. Bodily Pain 
23. How much bodily pain have you had during the past 4 weeks? 
 None (1) Very mild (2)  Mild (3)  Moderate (4)  Severe (5)  Very Severe (6) 
24. During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the 
home and housework)?   
Not at all (1) Slightly (2) Moderately (3) Quite a bit (4) Extremely (5) 
vi. Vitality and vii Mental Health 
These questions are about how you feel and how things have been with you during the past 4 weeks.  For each 
question, please give the one answer that comes closest to the way you have been feeling.  
How much of the time during the past 4 weeks 
All of the time (1)  Most of the time (2)  A good bit of the time (3)  Some of the time (4)  None of the time (5) 
25.  Did you feel full of pep? 
26.  Have you been a very nervous person? 
27.  Have you felt so down in the dumps nothing could cheer you up? 
28.  Have you felt calm and peaceful? 
29.  Did you have a lot of energy? 
30.  Have you felt downhearted and blue? 
31.  Did you feel worn out? 
32.  Have you been a happy person? 
33.  Did you feel tired? 
ix. Social Functioning 
34. During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your 
normal social activities with friends, neighbors or groups? 
35. During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with 
your social activities (like visiting friends, relatives, etc.)? 
     All of the time (1)  Most of the time (2)  A good bit of the time (3)  Some of the time (4)  None of the time (5) 
 
36. Compared to before your breast cancer diagnosis, how would you rate your health in general 
now? Much better now (1) Somewhat better now (2) About the same (3) Somewhat worse (4) Much 
worse now (5) 
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Appendix D: Steps for conversion of MOS SF-36 into eight HRQOL sub-scales with values 
ranging between 0 – 100 (146). 
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Appendix E: Medical Outcome Study Social Support survey with 9-items 
 
 
People sometimes look to others for companionship, assistance, or other types of support. How 
often is each of the following kinds of support available to you if you need it now? 
None of the time (1) A little of the time (2) Some of the time (3) Most of the time (4) All of the 
time (5) 
  
1 Someone to help you if you were confined to bed 
2 Someone who shows you love and affection 
 3 Someone to take you to the doctor if you needed it 
 4 Someone to confide in or talk about yourself or your problems 
 5 Someone who hugs you 
6 Someone to get together with for relaxation 
7 Someone to help with daily chores if you were sick 
8 Someone to turn to for suggestions about how to deal with a personal problem 
 9 Someone to love and make you feel wanted 
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Appendix F: Stepwise forward selection multiple regression for PCS scores 
 
 
Predictor variables 
Outcome variable 
Physical component summary scores (PCS) 
N = 515 
 β a (95% Confidence Interval) P-value 
Individual-related variables   
Demographic factors   
Menopause   
     Premenopausal   Reference category  
     Postmenopausal -2.1 (-3.9 to -0.3) 0.02* 
Treatment related factors   
Stage of breast cancer   
     0 –I  Reference category  
     II  1.9 (-0.1 to 3.7) 0.03* 
Received chemotherapy   
     No  Reference category  
     Yes -4.5 (-6.7 to -2.5) 0.00* 
Number of co-morbidities   
     None Reference category  
     One -3.0 (-4.9 to -1.0) 0.003* 
     ≥ 2 -6.3 (-8.8 to -3.7) 0.00* 
Treatment side effects   
     ≤ 5  Reference category  
     > 5 -3.6 (-5.6 to -1.6) 0.00* 
Did not report any side effects -2.5 (-4.8 to -0.3) 0.03* 
Psycho-social factors   
Depression   
     No  Reference category  
     Yes -4.7 (-6.5 to -3.0) 0.00* 
                                                                              Continued on the next page… 
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*Significant at 0.05% level                                                                                                                                       
a : regression co-efficient                                                                                                                                                                        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Systems-related variables   
Health systems related factors   
Satisfaction with treatment by oncologist  
     Extremely satisfied  Reference category  
     Not extremely satisfied -1.4 (-3.4 to 0.5) 0.1 
Satisfaction with treatment by radiation oncologist 
     Extremely satisfied  Reference category  
     Not extremely satisfied -2.7 (-5.4 to -0.1) 0.06 
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Appendix G: Stepwise backward elimination multiple regression for PCS scores 
 
 
Predictor variables 
Outcome variable 
Physical component summary scores (PCS) 
N = 515 
 β a (95% Confidence Interval) P-value 
Individual-related variables   
Demographic factors   
Age 0.05 (-0.03 to 0.1) 0.2 
Menopause   
     Premenopausal   Reference category  
     Postmenopausal -2.4 (-3.9 to -0.3) 0.009* 
Treatment related factors   
Stage of breast cancer   
     0 –I  Reference category  
     II  1.4 (-0.7 to 3.4) 0.1 
     III – IV -2.0 (-5.0 to 0.9) 0.1 
Type of surgery   
     Mastectomy only Reference category  
     Mastectomy and breast 
conserving surgery  
1.6 (-0.8 to 4.04) 0.2 
Received chemotherapy   
     No  Reference category  
     Yes -4.0 (-6.4 to -1.7) 0.001* 
Received radiation therapy   
     No  Reference category  
     Yes 5.3 (0.2 to 10.4) 0.04* 
Number of co-morbidities   
     None Reference category  
     One -2.8 (-4.8 to -0.8) 0.006* 
     ≥ 2 -6.3 (-8.8 to -3.7) 0.00* 
                                                                              Continued on the next page… 
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*Significant a* Significant at 0.05% level                                                                                                                                                   
a : regression co-efficient                                                                                                                                                                        
 
 
 
 
 
 
 
 
 
Treatment side effects   
     ≤ 5  Reference category  
     > 5 -3.7 (-5.8 to -1.7) 0.00* 
Did not report any side effects -2.5 (-4.8 to -0.2) 0.03* 
Psycho-social factors   
Depression   
     No  Reference category  
     Yes -4.8 (-6.6 to -3.0) 0.00* 
Systems-related variables   
Health systems related factors   
Satisfaction with treatment by oncologist  
     Extremely satisfied  Reference category  
     Not extremely satisfied -1.4 (-3.4 to 0.6) 0.2 
Satisfaction with treatment by radiation oncologist 
     Extremely satisfied  Reference category  
     Not extremely satisfied -2.7 (-5.4 to -0.1) 0.04* 
     Did not receive radiation therapy 4.7 (-0.5 to 9.8) 0.07 ** 
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Appendix H: Stepwise forward selection multiple regression for MCS scores 
 
 
Predictor variables 
Outcome variable 
Mental component summary scores (MCS) 
N = 515 
 β a (95% Confidence Interval) P-value 
Key predictor variable   
Perceived social support 0.03 (-0.008 to 0.06) 0.1 
Individual-related variables   
Treatment related factors   
Stage of breast cancer   
     0 –I  Reference category  
     III – IV -1.9 (-4.7 to 0.9) 0.2 
Number of co-morbidities   
     None Reference category  
     ≥ 2 -2.0 (-4.8 to 0.6) 0.1 
Treatment side effects   
     ≤ 5  Reference category  
     > 5 -2.7 (-4.7 to -0.7) 0.008* 
Psycho-social factors   
Anxiety   
     No  Reference category  
     Yes -4.8 (-6.6 to -3.0) 0.00* 
Depression   
     No  Reference category  
     Yes -6.7 (-8.8 to -4.6) 0.00* 
Systems-related variables   
Satisfaction with treatment by radiation oncologist  
     Extremely satisfied  Reference category  
     Not extremely satisfied -2.0 (-4.8 to -0.8)  0.2 
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*Significant a* Significant at 0.05% level                                                                                                 
a : regression co-efficient                                                                                                                                                                        
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Appendix I: Stepwise backward elimination multiple regression for MCS scores 
 
 
Predictor variables 
Outcome variable 
Mental component summary scores (MCS) 
N = 515 
 β a (95% Confidence Interval) P-value 
Key predictor variable   
Perceived social support 0.03 (-0.008 to 0.06) 0.1 
Individual-related variables   
Treatment related factors   
Stage of breast cancer   
     0 –I  Reference category  
     III – IV -1.9 (-4.8 to 0.9) 0.2 
Number of co-morbidities   
     None Reference category  
     ≥ 2 -2.0 (-4.8 to 0.6) 0.1 
Treatment side effects   
     ≤ 5  Reference category  
     > 5 -2.7 (-4.7 to -0.7) 0.008* 
Psycho-social factors   
Anxiety   
     No  Reference category  
     Yes -4.2 (-6.6 to -1.9) 0.00* 
Depression   
     No  Reference category  
     Yes -6.7 (-8.8 to -4.6) 0.00* 
Systems-related variables   
Satisfaction with treatment by radiation oncologist  
     Extremely satisfied  Reference category  
     Not extremely satisfied -2.0 (-4.8 to -0.8)  0.2 
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*Significant a* Significant at 0.05% level                                                                                                                                        
a : regression co-efficient                                                                                                                                                                        
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Appendix J: Regression diagnostic plots for PCS scores 
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Appendix K: Regression diagnostic plots for MCS scores  
 
           Kernel density plot            Normal probability plot 
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